https://curecurrent.com/trials/trial-to-assess-the-efficacy-and-safety-of-spm-927-200-400-and-600mg-day-in-subjects-with-painful-distal-diabetic-neurop-7001https://curecurrent.com/trials/the-effects-of-the-food-preservative-propionic-acid-in-post-prandial-metabolism-7002https://curecurrent.com/trials/improving-control-and-reducing-the-risk-of-hypoglycemic-episodes-in-type-1-diabetes-7003https://curecurrent.com/trials/multiple-dose-study-of-pf-05231023-in-obese-adult-subjects-7004https://curecurrent.com/trials/an-efficacy-safety-and-tolerability-study-of-canagliflozin-in-the-treatment-of-patients-with-type-2-diabetes-mellitus-wi-7005https://curecurrent.com/trials/islet-after-kidney-transplant-for-type-1-diabetes-7006https://curecurrent.com/trials/the-multi-sensor-distance-accuracy-study-7007https://curecurrent.com/trials/outpatient-control-to-range-system-and-monitoring-testing-7008https://curecurrent.com/trials/effects-of-standing-on-glycemia-in-prediabetic-adults-7009https://curecurrent.com/trials/goodmoms-a-multimodel-pregnancy-and-postpartum-intervention-for-gestational-diabetics-7010https://curecurrent.com/trials/early-feasibility-study-2-of-outpatient-control-to-range-testing-system-efficacy-7011https://curecurrent.com/trials/safety-and-efficacy-of-peg-encapsulated-islet-allografts-implanted-in-type-i-diabetic-recipients-7012https://curecurrent.com/trials/idecide-decido-diabetes-medication-decision-support-study-7013https://curecurrent.com/trials/a-bioequivalence-study-of-the-fixed-dose-combination-tablets-of-canagliflozin-and-metformin-extended-release-xr-with-res-7014https://curecurrent.com/trials/low-glycemic-load-diets-in-latino-children-at-risk-for-type-2-diabetes-7015https://curecurrent.com/trials/peer-led-self-management-support-in-real-world-clinical-and-community-settings-7016https://curecurrent.com/trials/safety-study-of-subcutaneously-injected-prandial-insulin-ph20-np-compared-to-insulin-lispro-injection-in-participants-wi-7017https://curecurrent.com/trials/effect-of-statins-on-oxidative-stress-and-endothelial-progenitor-cells-7018https://curecurrent.com/trials/the-association-between-unprotected-standing-walking-and-wound-healing-in-diabetes-7019https://curecurrent.com/trials/counter-regulatory-impairment-and-the-effect-of-microvascular-insulin-transfer-in-type-1-diabetes-mellitus-7020https://curecurrent.com/trials/pediatric-diabetics-type-1-using-insupatch-7021https://curecurrent.com/trials/development-of-a-behavioral-observer-for-type-1-diabetes-mellitus-7022https://curecurrent.com/trials/comparison-of-phase-variance-optical-coherence-tomography-and-fluorescein-angiography-in-retinovascular-imaging-7023https://curecurrent.com/trials/pilot-study-of-closed-loop-glucose-control-in-people-with-type-1-diabetes-bpk004-7024https://curecurrent.com/trials/a-nutritional-intervention-for-diabetic-neuropathy-7025https://curecurrent.com/trials/evaluation-of-the-effect-of-the-insupatch-device-on-insulin-pharmacokinetics-in-clamp-studies-7026https://curecurrent.com/trials/evaluation-of-the-safety-use-of-the-insupatch-device-in-daily-life-conditions-7027https://curecurrent.com/trials/a-bioequivalence-study-of-the-fixed-dose-combination-tablets-of-canagliflozin-and-metformin-extended-release-xr-with-res-7028https://curecurrent.com/trials/a-study-to-compare-analyte-levels-in-blood-samples-collected-using-the-tap20-c-device-with-results-obtained-by-fingersti-7029https://curecurrent.com/trials/glycemic-response-to-high-amylose-rice-7030https://curecurrent.com/trials/diet-and-activity-promotion-among-older-working-adults-7031https://curecurrent.com/trials/determination-of-safety-tolerability-pharmacokinetics-food-effect-pharmacodynamics-of-single-multiple-doses-of-p11187-7032https://curecurrent.com/trials/eating-disorders-in-type-1-diabetes-mechanisms-of-comorbidity-7033https://curecurrent.com/trials/simcare-physician-intervention-to-improve-diabetes-care-7034https://curecurrent.com/trials/safety-efficacy-study-of-subcutaneously-injected-prandial-insulins-compared-to-insulin-lispro-alone-in-patients-with-typ-7035https://curecurrent.com/trials/liquid-meal-study-with-insulin-lispro-with-without-recombinant-human-hyaluronidase-ph20-rhuph20-and-regular-human-insuli-7036https://curecurrent.com/trials/hypoglycemia-prevention-after-exercise-in-adolescent-t1dm-patients-using-a-control-to-range-system-7037https://curecurrent.com/trials/prosthetic-components-and-stability-in-amputee-gait-7038https://curecurrent.com/trials/feasibility-study-of-closed-loop-control-in-type-1-diabetes-using-heart-rate-monitoring-as-an-exercise-marker-7039https://curecurrent.com/trials/vacuum-suspension-effects-on-tissue-oxygenation-activity-and-fit-7040https://curecurrent.com/trials/the-careful-prevention-trial-7041https://curecurrent.com/trials/the-avoiding-diabetes-thru-action-plan-targeting-pilot-randomized-control-trial-7042https://curecurrent.com/trials/sensor-based-balance-training-in-diabetes-a-virtual-reality-paradigm-7043https://curecurrent.com/trials/daily-tadalafil-and-gastric-emptying-time-in-diabetic-gastroparesis-7044https://curecurrent.com/trials/subcutaneous-administration-of-lisofylline-to-healthy-normal-subjects-and-subjects-with-type-1-diabetes-7045https://curecurrent.com/trials/randomized-double-blind-crossover-pharmacokinetic-pk-and-glucodynamic-gd-study-of-continuous-subcutaneous-insulin-infusi-7046https://curecurrent.com/trials/effect-of-maraviroc-on-endothelial-function-in-hiv-infected-patients-7047https://curecurrent.com/trials/using-santyl-on-diabetic-foot-ulcers-7048https://curecurrent.com/trials/study-to-evaluate-the-efficacy-of-androxal-in-controlling-blood-glucose-in-men-with-type-2-diabetes-mellitus-7049https://curecurrent.com/trials/comparison-of-apidra-to-regular-insulin-in-hospitalized-patients-7050https://curecurrent.com/trials/pilot-study-of-the-effect-of-mn-504-cobiotic-formulation-on-the-efficacy-and-tolerability-of-metformin-7051https://curecurrent.com/trials/effects-of-a-homeopathic-anti-inflammatory-topical-cream-on-ulcers-and-neuropathy-in-the-diabetic-foot-7052https://curecurrent.com/trials/xenin-25-novel-regulator-of-insulin-secretion-and-beta-cell-function-7053https://curecurrent.com/trials/pharmacokinetic-and-glucodynamic-crossover-study-of-subcutaneously-sc-administered-insulin-lispro-recombinant-human-hyal-7054https://curecurrent.com/trials/personalized-cardiovascular-risk-information-to-initiate-and-maintain-health-behavior-changes-7055https://curecurrent.com/trials/a-randomized-double-blind-study-testing-the-effects-of-pregabalin-on-diabetic-neuropathy-7056https://curecurrent.com/trials/a-pilot-study-of-moderate-hyperbilirubinemia-in-type-1-diabetes-mellitus-7057https://curecurrent.com/trials/a-mobile-based-diabetes-prevention-program-7058https://curecurrent.com/trials/effects-of-aerobic-exercise-in-patients-with-pre-diabetes-7059https://curecurrent.com/trials/does-saxagliptin-reduce-the-risk-of-cardiovascular-events-when-used-alone-or-added-to-other-diabetes-medications-7060https://curecurrent.com/trials/characterization-of-the-variability-of-insulin-secretory-parameters-in-the-meal-tolerance-and-the-maximal-stimulation-te-7061https://curecurrent.com/trials/supreme-dm-diabetes-mellitis-treatment-study-7062https://curecurrent.com/trials/tailored-case-management-for-diabetes-and-hypertension-7063https://curecurrent.com/trials/exercise-dose-response-effects-in-prediabetes-7064https://curecurrent.com/trials/safety-and-efficacy-of-empagliflozin-bi-10773-and-sitagliptin-versus-placebo-over-76-weeks-in-patients-with-type-2-diabe-7065https://curecurrent.com/trials/a-crossover-study-of-the-acute-effects-of-olanzapine-in-healthy-volunteers-7066https://curecurrent.com/trials/pharmacokinetics-of-a-fixed-dose-combination-of-canagliflozin-metformin-coadministered-with-food-7067https://curecurrent.com/trials/safety-and-efficacy-of-ingap-peptide-in-patients-with-type-1-diabetes-7068https://curecurrent.com/trials/an-evaluation-of-the-efficacy-and-safety-of-e2007-in-patients-with-painful-diabetic-neuropathy-7069https://curecurrent.com/trials/effects-of-resistant-starch-in-a-baked-snack-bar-on-a-post-prandial-glycemic-and-insulinemic-response-7070https://curecurrent.com/trials/safety-and-efficacy-of-ingap-peptide-in-patients-with-type-2-diabetes-7071https://curecurrent.com/trials/diabetes-group-visits-7072https://curecurrent.com/trials/veteran-health-study-7073https://curecurrent.com/trials/effect-of-a-high-protein-diet-on-the-24-hour-profile-of-ghrelin-gh-growth-hormone-and-igf-1-insulin-like-growth-factor-1-7074https://curecurrent.com/trials/a-very-high-fiber-diet-versus-a-low-carbohydrate-diet-for-weight-loss-7075https://curecurrent.com/trials/efficacy-and-safety-of-metoclopramide-nasal-spray-solution-in-diabetic-patients-with-gastroparesis-7076https://curecurrent.com/trials/correlation-of-plasma-endothelial-cell-activity-with-cardiovascular-events-in-patients-with-diabetes-mellitus-type-2-7077https://curecurrent.com/trials/safety-and-efficacy-of-linagliptin-bi-1356-as-monotherapy-or-in-combination-in-type-2-dm-7078https://curecurrent.com/trials/safety-and-efficacy-of-linagliptin-in-type-2-diabetes-mellitus-patients-with-moderate-to-severe-renal-impairment-7079https://curecurrent.com/trials/non-traditional-cardiovascular-risk-factors-and-atherosclerosis-in-type-2-diabetes-7080https://curecurrent.com/trials/randomized-double-blind-db-placebo-controlled-18-week-study-of-linagliptin-bi-1356-in-type-2-diabetic-patients-with-insu-7081https://curecurrent.com/trials/a-randomised-db-placebo-controlled-study-of-bi-1356-for-18-weeks-followed-by-a-34-week-double-blind-extension-period-pla-7082https://curecurrent.com/trials/pharmacokinetics-and-pharmacodynamics-trial-with-linagliptin-bi-1356-5mg-in-african-american-type-2-diabetic-patients-7083https://curecurrent.com/trials/safety-and-efficacy-of-once-daily-krp-104-in-type-2-diabetics-with-inadequate-glycemic-control-on-metformin-alone-7084https://curecurrent.com/trials/efficacy-and-safety-study-with-empagliflozin-bi-10773-vs-placebo-as-add-on-to-metformin-or-metformin-plus-sulfonylurea-o-7085https://curecurrent.com/trials/safety-and-efficacy-of-bi-10773-as-add-on-to-insulin-regimen-in-patients-with-type-2-diabetes-mellitus-7086https://curecurrent.com/trials/prevention-of-type-2-diabetes-in-children-with-a-family-based-healthy-lifestyle-program-7087https://curecurrent.com/trials/a-bioequivalence-study-of-the-fixed-dose-combination-tablets-of-canagliflozin-and-metformin-extended-release-xr-with-res-7088https://curecurrent.com/trials/strategies-for-inflammation-and-cardiovascular-disease-cvd-prevention-7089https://curecurrent.com/trials/efficacy-and-safety-of-empagliflozin-bi-10773-in-type-2-diabetes-patients-on-a-background-of-pioglitazone-alone-or-with-7090https://curecurrent.com/trials/efficacy-and-safety-of-empagliflozin-bi-10773-versus-placebo-and-sitagliptin-over-24-weeks-in-patients-with-type-2-diabe-7091https://curecurrent.com/trials/empagliflozin-bi-10773-in-type-two-diabetes-t2d-patients-open-label-extension-7092https://curecurrent.com/trials/efficacy-and-safety-of-empagliflozin-bi-10773-in-patients-with-type-2-diabetes-and-renal-impairment-7093https://curecurrent.com/trials/dapagliflozin-dppiv-inhibitor-add-on-study-7094https://curecurrent.com/trials/bi-10773-add-on-to-metformin-in-patients-with-type-2-diabetes-7095https://curecurrent.com/trials/effects-of-resistant-starch-in-a-beverage-on-post-prandial-glycemic-and-insulinemic-responses-7096https://curecurrent.com/trials/insulin-detemir-versus-nph-insulin-in-hospitalized-patients-with-diabetes-7097https://curecurrent.com/trials/b-lymphocyte-immunotherapy-in-islet-transplantation-for-initial-islet-graft-failure-7098https://curecurrent.com/trials/study-of-a-home-delivered-meal-program-on-obese-elderly-african-american-subjects-with-type-2-diabetes-mellitus-dm-7099https://curecurrent.com/trials/effects-of-a-spiced-meat-patty-on-inflammation-in-men-with-type-2-diabetes-7100https://curecurrent.com/trials/an-rct-evaluation-of-a-diabetes-dashboard-team-model-in-primary-care-7101https://curecurrent.com/trials/evaluating-a-web-based-cardiovascular-disease-risk-factor-reduction-program-among-american-indians-7102https://curecurrent.com/trials/haptoglobin-phenotype-vitamin-e-and-high-density-lipoprotein-hdl-function-in-type-1-diabetes-7103https://curecurrent.com/trials/personalized-diabetic-kidney-disease-risk-info-to-initiate-and-maintain-health-behavior-changes-7104https://curecurrent.com/trials/transition-of-adolescents-and-young-adults-with-diabetes-from-pediatric-to-adult-care-7105https://curecurrent.com/trials/evaluation-of-the-accuracy-of-the-abbott-sensor-based-interstitial-glucose-monitoring-system-7106https://curecurrent.com/trials/taste-perception-and-chronic-disease-risk-7107https://curecurrent.com/trials/fatty-acid-binding-protein-2-fabp2-ancillary-proposal-7108https://curecurrent.com/trials/markers-and-mechanisms-of-vascular-disease-in-type-ii-diabetes-7109https://curecurrent.com/trials/evaluation-of-the-blood-levels-of-the-drug-lixisenatide-the-plasma-glucose-levels-and-safety-in-paediatric-and-adult-pat-7110https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-pharmacokinetics-explores-what-the-body-does-to-the-drug-and-pharmacodynamic-7111https://curecurrent.com/trials/novel-adjuvants-for-peptide-based-melanoma-vaccines-7112https://curecurrent.com/trials/role-of-mobile-technology-to-improve-diabetes-care-in-adults-with-type-1-diabetes-the-remote-t1d-study-a-pilot-study-7113https://curecurrent.com/trials/study-of-insulin-resistance-and-endometrial-cancer-in-harris-county-texas-7114https://curecurrent.com/trials/personalized-exercise-for-adolescents-with-diabetes-7115https://curecurrent.com/trials/the-study-of-exenatide-action-on-vessel-function-in-type-2-diabetes-and-prediabetes-7116https://curecurrent.com/trials/linagliptin-and-metformin-versus-linagliptin-in-newly-diagnosed-untreated-type-2-diabetes-7117https://curecurrent.com/trials/efficacy-of-colesevelam-in-subjects-with-type-1-diabetes-mellitus-7118https://curecurrent.com/trials/safety-and-efficacy-in-type-2-diabetic-patients-with-severe-chronic-renal-impairment-5-mg-bi-1356-linagliptin-vs-placebo-7119https://curecurrent.com/trials/care-transitions-for-complex-patient-cycle-1-and-cycle-2-7120https://curecurrent.com/trials/aldosterone-breakthrough-during-diovan-tekturna-and-combination-therapy-in-patients-with-proteinuric-kidney-disease-7121https://curecurrent.com/trials/cardiovascular-risk-clinic-7122https://curecurrent.com/trials/amg-151-amgen-protocol-number-20100761-7123https://curecurrent.com/trials/transdermal-continuous-oxygen-therapy-for-diabetic-foot-ulcers-7124https://curecurrent.com/trials/mitochondrial-dysfunction-in-diabetes-7125https://curecurrent.com/trials/pgc-1-and-mitochondrial-dysfunction-in-diabetes-7126https://curecurrent.com/trials/evaluating-the-safety-and-tolerability-of-oravescent-fentanyl-for-opioid-tolerant-patients-with-noncancer-related-breakt-7127https://curecurrent.com/trials/hope-pilot-for-veterans-with-complex-diabetes-7128https://curecurrent.com/trials/efficacy-study-of-lucentis-in-the-treatment-of-diabetic-macular-edema-7129https://curecurrent.com/trials/detection-of-c-peptide-in-youth-with-longstanding-type-1-diabetes-mellitus-7130https://curecurrent.com/trials/using-salsalate-to-target-adipocyte-macrophage-infiltration-7131https://curecurrent.com/trials/nurse-led-case-management-for-diabetes-and-cardiovascular-disease-patients-with-depression-7132https://curecurrent.com/trials/cardiovascular-outcomes-study-of-alogliptin-in-patients-with-type-2-diabetes-and-acute-coronary-syndrome-7133https://curecurrent.com/trials/continuous-glucose-monitoring-cgm-in-subjects-with-type-2-diabetes-7134https://curecurrent.com/trials/study-of-iv-ym087-to-assess-efficacy-and-safety-in-patients-with-euvolemic-or-hypervolemic-hyponatremia-7135https://curecurrent.com/trials/pramlintide-combined-with-model-predictive-control-algorithm-7136https://curecurrent.com/trials/a-study-to-investigate-the-safety-and-clinical-effect-of-nexagon-as-a-topical-treatment-for-subjects-with-a-diabetic-foo-7137https://curecurrent.com/trials/flavanol-rich-cocoa-and-cerebral-blood-flow-7138https://curecurrent.com/trials/accuracy-of-blood-glucose-detection-by-diabetes-alert-dogs-7139https://curecurrent.com/trials/evaluation-of-a-simulation-based-educational-tool-for-personalized-feedback-in-insulin-therapy-management-7140https://curecurrent.com/trials/randomized-controlled-trial-of-vitamin-d3-in-diabetic-kidney-disease-7141https://curecurrent.com/trials/intensive-discharge-intervention-in-diabetes-7142https://curecurrent.com/trials/coronary-artery-revascularization-in-diabetes-7143https://curecurrent.com/trials/mitochondrial-dysfunction-in-type-2-diabetes-mellitus-and-capacity-for-fat-oxidation-during-exercise-7144https://curecurrent.com/trials/cost-effectiveness-and-quality-of-life-in-heart-failure-patients-with-diabetes-7145https://curecurrent.com/trials/blood-pressure-telemonitoring-and-goal-blood-pressure-in-diabetes-7146https://curecurrent.com/trials/study-of-insulin-lispro-in-participants-with-inadequately-controlled-type-2-diabetes-7147https://curecurrent.com/trials/study-of-raisins-versus-alternative-snacks-in-patients-with-type-2-diabetes-mellitus-7148https://curecurrent.com/trials/a-safety-tolerability-pharmacokinetics-and-pharmacodynamics-study-of-jnj-28431754-in-patients-with-type-2-diabetes-melli-7149https://curecurrent.com/trials/computer-detection-of-diabetic-retinopathy-compared-to-clinical-examination-7150https://curecurrent.com/trials/the-role-of-apathy-in-glycemic-control-7151https://curecurrent.com/trials/inspire-diabetes-study-basal-bolus-insulin-as-primary-treatment-of-type-2-diabetes-7152https://curecurrent.com/trials/comparison-study-of-lay-person-finger-stick-versus-blood-draw-7153https://curecurrent.com/trials/aliskiren-trial-in-type-2-diabetes-using-cardiovascular-and-renal-disease-endpoints-core-and-extension-phases-7154https://curecurrent.com/trials/a-low-carbohydrate-ketogenic-diet-versus-orlistat-for-weight-loss-7155https://curecurrent.com/trials/strategies-to-maintain-cardiac-risk-control-after-discharge-from-cardiovascular-risk-reduction-clinic-7156https://curecurrent.com/trials/a-randomized-double-blind-comparator-and-placebo-controlled-multiple-dose-study-to-evaluate-the-safety-tolerability-and-7157https://curecurrent.com/trials/effectiveness-of-dermapace-device-and-standard-treatment-compared-to-standard-treatment-alone-for-diabetic-foot-ulcers-7158https://curecurrent.com/trials/efficacy-assessment-of-insulin-glargine-versus-liraglutide-after-oral-agents-failure-7159https://curecurrent.com/trials/multi-targeted-cardiac-risk-intervention-in-type-2-diabetes-7160https://curecurrent.com/trials/effect-of-type-2-diabetes-genetic-risk-information-on-health-behaviors-and-outcomes-7161https://curecurrent.com/trials/grafix-dfu-open-label-extension-option-to-evaluate-safety-efficacy-of-grafix-for-chronic-diabetic-foot-ulcers-7162https://curecurrent.com/trials/the-effects-of-sevelamer-carbonate-on-diabetic-nephropathy-7163https://curecurrent.com/trials/lifestyle-change-to-prevent-diabetes-via-african-american-churches-7164https://curecurrent.com/trials/vitamin-d-and-adipose-tissue-inflammation-7165https://curecurrent.com/trials/adopting-a-physically-active-lifestyle-through-organized-walk-events-among-joslin-clinic-patients-7166https://curecurrent.com/trials/effects-of-colesevelam-on-how-the-body-responds-to-insulin-in-patients-with-type-2-diabetes-7167https://curecurrent.com/trials/multiple-dose-pharmacokinetics-of-canagliflozin-metformin-150-1-000-mg-fixed-dose-combination-7168https://curecurrent.com/trials/tactics-targeting-adherence-to-cholesterol-lowering-therapy-to-improve-control-study-7169https://curecurrent.com/trials/comparative-effectiveness-of-bariatric-surgery-versus-medical-management-to-induce-diabetes-remission-in-diabetic-patien-7170https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-ranolazine-on-postprandial-glucagon-in-subjects-with-type-2-diabetes-7171https://curecurrent.com/trials/identifying-and-overcoming-barriers-to-diabetes-management-in-the-elderly-a-cost-effective-intervention-study-7172https://curecurrent.com/trials/identifying-and-overcoming-barriers-to-diabetes-management-in-the-elderly-an-intervention-study-7173https://curecurrent.com/trials/type-1-diabetes-mellitus-bone-mineral-density-in-childhood-and-adolescence-7174https://curecurrent.com/trials/linagliptin-versus-placebo-in-type-2-diabetic-patients-with-inadequate-glycaemic-control-on-metformin-in-combination-wit-7175https://curecurrent.com/trials/maintaining-resistance-training-in-older-prediabetic-adults-7176https://curecurrent.com/trials/safety-and-efficacy-study-of-insulin-lispro-versus-insulin-aspart-in-participants-with-type-2-diabetes-on-insulin-pump-t-7177https://curecurrent.com/trials/impact-of-web-based-care-management-for-poorly-controlled-type-2-diabetes-mellitus-a-randomized-controlled-trial-7178https://curecurrent.com/trials/walnuts-and-glucose-variability-7179https://curecurrent.com/trials/use-of-integra-flowable-wound-matrix-to-manage-diabetic-foot-ulcers-7180https://curecurrent.com/trials/outpatient-study-to-evaluate-safety-and-effectiveness-of-the-low-glucose-suspend-feature-7181https://curecurrent.com/trials/tri-staple-technology-stapler-used-in-gastric-bypass-7182https://curecurrent.com/trials/efficacy-and-safety-of-3-doses-of-bi1356-linagliptin-in-type-2-diabetes-patients-7183https://curecurrent.com/trials/janssen-glucose-regulation-risp-olanz-7184https://curecurrent.com/trials/desensitization-for-highly-sensitized-recipients-of-pancreas-transplantation-7185https://curecurrent.com/trials/pfizer-ivgtt-ziprasidone-olanzapine-7186https://curecurrent.com/trials/basal-bolus-insulin-versus-ssri-in-type-2-diabetes-undergoing-general-surgery-7187https://curecurrent.com/trials/telmisartan-fixed-dose-combination-vs-amlodipine-in-hypertensive-patients-with-type-2-diabetes-mellitus-7188https://curecurrent.com/trials/sleep-apnea-in-look-ahead-action-for-health-in-diabetes-7189https://curecurrent.com/trials/a-comparison-of-the-dermapace-pulsed-acoustic-cellular-expression-device-in-conjunction-with-standard-of-care-versus-sta-7190https://curecurrent.com/trials/a-long-term-safety-study-with-tapentadol-er-and-oxycodone-cr-in-patients-with-moderate-to-severe-pain-due-to-chronic-pai-7191https://curecurrent.com/trials/welchol-as-monotherapy-for-type-2-diabetes-mellitus-7192https://curecurrent.com/trials/the-autologel-post-market-surveillance-taps-program-7193https://curecurrent.com/trials/rilonacept-in-diabetes-mellitus-type-1-safety-study-7194https://curecurrent.com/trials/phase-2-study-of-adaptive-insulin-meal-supervisor-aims-in-adults-with-type-1-diabetes-mellitus-7195https://curecurrent.com/trials/efficacy-and-safety-in-patients-with-type-2-diabetes-mellitus-and-cardiovascular-disease-7196https://curecurrent.com/trials/dipeptidyl-peptidase-4-inhibition-and-immune-function-in-hiv-7197https://curecurrent.com/trials/study-to-evaluate-the-safety-and-efficacy-of-paz320-in-patients-with-type-2-diabetes-7198https://curecurrent.com/trials/tolerability-safety-and-efficacy-study-of-ingap-peptide-to-treat-type-1-diabetes-mellitus-in-adults-7199https://curecurrent.com/trials/insulin-infusion-in-the-hospital-wards-7200https://curecurrent.com/trials/glyburide-compared-to-insulin-in-the-management-of-white-s-classification-a2-gestational-diabetes-7201https://curecurrent.com/trials/a-phase-1b-study-of-laps-exendin-in-subjects-of-type-2-diabetes-mellitus-7202https://curecurrent.com/trials/expanding-comparative-effectiveness-research-cer-capability-through-complex-patient-relationship-management-7203https://curecurrent.com/trials/u-500r-insulin-in-type-2-diabetes-with-severe-insulin-resistance-via-omnipod-7204https://curecurrent.com/trials/results-of-tc99m-maraciclatide-scintigraphy-in-subjects-with-diabetes-mellitus-and-heart-failure-with-preserved-left-ven-7205https://curecurrent.com/trials/randomized-prospective-evaluation-of-the-toad-brace-in-plantar-ulcer-off-loading-and-healing-7206https://curecurrent.com/trials/the-effect-of-exercise-training-intensity-in-patients-with-type-2-diabetes-7207https://curecurrent.com/trials/efficacy-and-safety-of-linagliptin-bi-1356-in-black-african-americans-with-type-2-diabetes-with-a-mtt-sub-study-7208https://curecurrent.com/trials/efficacy-and-safety-of-bi-1356-in-combination-with-metformin-in-patients-with-type-2-diabetes-7209https://curecurrent.com/trials/dose-ranging-study-of-the-glp-1-agonist-ave0010-in-metformin-treated-subjects-with-type-2-diabetes-mellitus-7210https://curecurrent.com/trials/efficacy-and-safety-of-b-i1356-linagliptin-vs-placebo-added-to-metformin-background-therapy-in-patients-with-type-2-diab-7211https://curecurrent.com/trials/evaluation-of-the-effects-of-hp828-101-versus-standard-of-care-in-the-management-of-partial-or-full-thickness-wounds-7212https://curecurrent.com/trials/fasiglifam-in-type-2-diabetic-subjects-with-chronic-kidney-disease-stage-4-or-5-on-hemodialysis-7213https://curecurrent.com/trials/aerobic-training-and-arterial-stiffness-in-chronic-kidney-disease-ckd-patients-7214https://curecurrent.com/trials/mechanism-of-insulin-resistant-in-lean-non-diabetics-7215https://curecurrent.com/trials/african-american-children-glycemic-control-and-type-2-diabetes-7216https://curecurrent.com/trials/diabetes-and-periodontal-therapy-trial-7217https://curecurrent.com/trials/barriers-to-treatment-in-obese-adolescents-7218https://curecurrent.com/trials/comparison-of-the-effect-of-intense-exercise-moderate-calorie-topiramate-phentermine-and-cognitive-behavioral-therapy-on-7219https://curecurrent.com/trials/vitamin-d-insulin-sensitivity-and-vascular-associations-in-adolescents-7220https://curecurrent.com/trials/vitamin-d-and-pregnancy-camden-study-7221https://curecurrent.com/trials/evaluation-of-topical-wound-oxygen-two2-therapy-7222https://curecurrent.com/trials/epigenetic-modifications-of-diabetes-mellitus-type-i-7223https://curecurrent.com/trials/insulin-delivery-using-microneedles-in-type-1-diabetes-7224https://curecurrent.com/trials/vagal-nerve-stimulation-and-glucose-metabolism-7225https://curecurrent.com/trials/glycemic-control-and-variability-for-congestive-heart-failure-exacerbation-7226https://curecurrent.com/trials/cardiovascular-risk-factors-body-composition-fitness-levels-and-quality-of-life-in-overweight-and-obese-8-17-year-olds-7227https://curecurrent.com/trials/efficacy-and-safety-of-linagliptin-in-combination-with-insulin-in-patients-with-type-2-diabetes-7228https://curecurrent.com/trials/a-pilot-study-of-the-effects-of-diet-and-behavioral-interventions-on-health-in-diabetics-7229https://curecurrent.com/trials/glycosa-study-effect-of-pap-treatment-on-glycemic-control-in-patients-with-type-2-diabetes-7230https://curecurrent.com/trials/st-of-tn-salud-con-la-familia-prevent-onset-of-ped-obesity-7231https://curecurrent.com/trials/situational-problem-solving-in-adolescents-with-type-2-diabetes-enhancing-a-randomized-controlled-trial-rct-7232https://curecurrent.com/trials/single-dose-single-administration-study-of-technosphere-inhalation-powder-in-diabetic-subjects-with-mild-or-moderate-kid-7233https://curecurrent.com/trials/effects-of-pistachios-on-cardiovascular-responses-to-stress-in-type-2-diabetes-7234https://curecurrent.com/trials/a-study-of-the-safety-pharmacokinetics-and-pharmacodynamics-of-cnto-3649-in-healthy-adults-and-patients-with-type-2-diab-7235https://curecurrent.com/trials/study-of-cholesterol-levels-and-types-in-african-americans-with-type-2-diabetes-7236https://curecurrent.com/trials/mechanisms-of-glucose-lowering-effects-of-sitagliptin-and-metformin-alone-and-in-combination-in-patients-with-t2dm-7237https://curecurrent.com/trials/tpn-induced-hyperglycemia-impact-on-clinical-outcome-in-intensive-care-unit-icu-and-non-icu-patients-7238https://curecurrent.com/trials/effects-of-nasulin-versus-placebo-on-blood-glucose-control-in-patient-volunteers-with-type-2-diabetes-mellitus-7239https://curecurrent.com/trials/comparative-study-of-two-application-regimens-of-amniotic-membrane-wound-graft-in-the-management-of-diabetic-foot-ulcers-7240https://curecurrent.com/trials/effect-of-resvida-a-comparison-with-calorie-restriction-regimen-7241https://curecurrent.com/trials/self-managed-walking-improves-function-7242https://curecurrent.com/trials/effects-of-environmental-opportunities-and-barriers-on-physical-activity-fitness-and-health-in-hispanic-children-in-wisc-7243https://curecurrent.com/trials/dpp-4-inhibition-and-tzd-for-dm-prevention-7244https://curecurrent.com/trials/cardiovascular-disease-cvd-risk-and-prevention-in-early-glucose-intolerance-7245https://curecurrent.com/trials/the-contribution-of-incretin-hormones-to-post-prandial-glucose-metabolism-after-roux-en-y-gastric-bypass-7246https://curecurrent.com/trials/the-contribution-of-incretin-hormones-to-the-amelioration-of-glucose-metabolism-after-roux-en-y-gastric-bypass-7247https://curecurrent.com/trials/effect-of-glycemic-variability-on-autonomic-tone-in-hospitalized-patients-with-type-2-diabetes-7248https://curecurrent.com/trials/efficacy-and-safety-of-alogliptin-plus-metformin-compared-to-glipizide-plus-metformin-in-patients-with-type-2-diabetes-m-7249https://curecurrent.com/trials/gip-glucose-dependent-insulinotropic-peptide-7250https://curecurrent.com/trials/a1c-fit-test-an-epidemiological-study-correlating-hemoglobin-a1c-with-results-of-the-air-force-physical-fitness-test-7251https://curecurrent.com/trials/exercise-and-type-2-diabetes-gender-and-endothelial-function-7252https://curecurrent.com/trials/study-on-copd-corticosteroid-induced-hyperglycemia-on-clinical-outcome-in-patients-with-copd-7253https://curecurrent.com/trials/diabetes-in-the-perioperative-period-7254https://curecurrent.com/trials/basal-bolus-versus-sliding-scale-insulin-in-hospitalized-patients-with-type-2-diabetes-7255https://curecurrent.com/trials/interferon-alpha-for-diabetes-mellitus-type-1-7256https://curecurrent.com/trials/partners-in-care-diabetes-self-management-intervention-7257https://curecurrent.com/trials/diabetes-in-the-elderly-retrospective-study-7258https://curecurrent.com/trials/ucsd-take-charge-study-7259https://curecurrent.com/trials/ketosis-prone-diabetes-in-african-americans-7260https://curecurrent.com/trials/the-effect-of-welchol-on-glucose-metabolism-in-type-2-diabetics-7261https://curecurrent.com/trials/smooth-blood-pressure-control-in-diabetic-obese-patients-7262https://curecurrent.com/trials/the-vascular-effects-of-exenatide-versus-metformin-in-patients-with-pre-diabetes-7263https://curecurrent.com/trials/automated-guidance-tool-for-medical-encounters-addressing-therapeutic-lifestyle-changes-augment-7264https://curecurrent.com/trials/determination-of-dosing-and-frequency-of-bcg-administration-to-alter-t-lymphocyte-profiles-in-type-i-diabetics-7265https://curecurrent.com/trials/study-comparing-two-methods-of-expanding-stents-placed-in-legs-of-diabetics-with-peripheral-vascular-disease-7266https://curecurrent.com/trials/effect-of-insulin-sensitizer-therapy-on-atherothrombotic-and-inflammatory-profiles-associated-with-insulin-resistance-7267https://curecurrent.com/trials/community-based-participatory-research-with-immigrant-chinese-with-diabetes-7268https://curecurrent.com/trials/a-2-week-trial-of-pf-04991532-in-patients-with-type-2-diabetes-7269https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-tolerability-of-pf-03882845-in-patients-with-type-2-diabetic-nephropathy-7270https://curecurrent.com/trials/efficacy-and-safety-of-dapagliflozin-added-to-therapy-of-patients-with-type-2-diabetes-with-inadequate-glycemic-control-7271https://curecurrent.com/trials/efficacy-and-safety-in-patients-with-type-2-diabetes-mellitus-cardiovascular-disease-and-hypertension-7272https://curecurrent.com/trials/triple-blockade-of-the-renin-angiotensin-aldosterone-system-in-diabetic-type-1-2-proteinuric-patients-7273https://curecurrent.com/trials/a-prospective-double-blind-placebo-controlled-multicenter-study-to-evaluate-efficacy-and-safety-of-atrasentan-including-7274https://curecurrent.com/trials/exercise-and-pioglitazone-for-hiv-metabolic-syndromes-7275https://curecurrent.com/trials/dendritic-cells-for-type-1-diabetes-mellitus-t1dm-therapy-7276https://curecurrent.com/trials/effect-of-whole-grain-diet-on-insulin-sensitivity-advanced-glycation-end-products-and-inflammatory-markers-in-pre-diabet-7277https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-use-of-episodic-intensive-blood-glucose-monitoring-in-persons-with-non-insulin-treated-7278https://curecurrent.com/trials/assessing-the-effectiveness-of-concurrent-peer-review-for-patients-with-cardiovascular-disease-and-diabetes-7279https://curecurrent.com/trials/diabetes-self-management-models-to-reduce-health-disparities-7280https://curecurrent.com/trials/use-of-terbutaline-or-a-reduction-in-basal-insulin-in-the-prevention-of-nocturnal-hypoglycemia-7281https://curecurrent.com/trials/exercise-study-to-help-patients-who-have-type-2-diabetes-and-depression-7282https://curecurrent.com/trials/fish-oil-and-aspirin-with-type-2-diabetes-7283https://curecurrent.com/trials/prevalence-of-dry-eyes-in-diabetics-compared-to-non-diabetics-7284https://curecurrent.com/trials/pilot-study-of-exercise-and-peripheral-nerve-function-in-people-with-diabetes-enrgy2-addendum-7285https://curecurrent.com/trials/a-culturally-tailored-lifestyle-intervention-to-prevent-diabetes-in-south-asians-7286https://curecurrent.com/trials/treating-the-endothelium-to-restore-insulin-sensitivity-7287https://curecurrent.com/trials/health-and-faith-salud-y-fe-community-based-diabetes-pilot-intervention-7288https://curecurrent.com/trials/fructose-induced-palmitate-synthesis-in-overweight-subjects-7289https://curecurrent.com/trials/the-effectiveness-of-improving-compliance-with-diabetic-preventative-services-and-modifying-vascular-risk-7290https://curecurrent.com/trials/exploratory-study-to-access-the-metabolic-effects-of-ranolazine-in-subjects-with-type-2-diabetes-mellitus-when-added-to-7291https://curecurrent.com/trials/near-infrared-light-nir-therapy-for-diabetic-macular-edema-a-pilot-study-7292https://curecurrent.com/trials/resveratrol-leucine-metabolite-synergy-in-pre-diabetes-7293https://curecurrent.com/trials/feasibility-study-assessing-the-ability-of-an-insulin-pump-controlling-algorithm-to-minimize-hypoglycemia-7294https://curecurrent.com/trials/multiple-dose-safety-tolerability-pharmacokinetics-and-midazolam-interaction-in-healthy-overweight-and-obese-subjects-7295https://curecurrent.com/trials/safety-pharmacokinetics-and-pharmacodynamics-of-dsp-8658-in-patients-with-type-2-diabetes-mellitus-and-healthy-adults-7296https://curecurrent.com/trials/a-6-week-pharmacokinetics-pharmacodynamics-safety-and-tolerability-of-gk1-399-in-type-2-diabetes-7297https://curecurrent.com/trials/effect-of-apidra-compared-to-humalog-in-decreasing-post-prandial-hyperglycemia-7298https://curecurrent.com/trials/glycemic-control-safety-and-tolerability-of-tc-6987-monotherapy-in-type-2-diabetes-mellitus-7299https://curecurrent.com/trials/lipid-metabolism-in-gestational-diabetes-7300https://curecurrent.com/trials/effect-of-a-community-based-nursing-intervention-on-mortality-in-chronically-ill-older-adults-7301https://curecurrent.com/trials/outpatient-treatment-of-gram-positive-wound-infections-in-the-diabetic-foot-a-pharmaco-economic-comparison-of-daptomycin-7302https://curecurrent.com/trials/study-to-evaluate-the-pharmacodynamic-and-pharmacokinetic-effects-of-lx4211-in-subjects-with-type-2-diabetes-and-renal-i-7303https://curecurrent.com/trials/the-genetics-of-kidneys-in-diabetes-gokind-study-7304https://curecurrent.com/trials/iv-insulin-protocol-in-diabetes-and-renal-transplantation-7305https://curecurrent.com/trials/multicenter-research-study-to-build-a-repository-to-study-chronic-diseases-in-indiana-7306https://curecurrent.com/trials/individual-differences-in-diabetes-risk-role-of-slow-wavesleep-7307https://curecurrent.com/trials/glucose-metabolism-and-sleep-in-people-with-family-history-of-type-2-diabetes-7308https://curecurrent.com/trials/pathways-linking-reduced-sleep-duration-and-quality-to-obesity-risk-7309https://curecurrent.com/trials/sleep-loss-and-glucose-metabolism-in-people-with-family-history-of-type-2-diabetes-7310https://curecurrent.com/trials/sleep-loss-and-energy-metabolism-in-people-with-family-history-of-type-2-diabetes-7311https://curecurrent.com/trials/sleep-disordered-breathing-and-diabetes-7312https://curecurrent.com/trials/chicago-childhood-diabetes-registry-7313https://curecurrent.com/trials/fitness-and-sleep-in-people-with-family-history-of-type-2-diabetes-7314https://curecurrent.com/trials/reach-out-chicago-children-s-diabetes-prevention-program-7315https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-single-doses-of-jnj-38431055-sitagl-7316https://curecurrent.com/trials/study-of-metanx-in-subjects-with-type-2-diabetic-peripheral-neuropathy-dpn-7317https://curecurrent.com/trials/impact-of-a-diabetes-risk-score-on-lifestyle-education-and-patient-adherence-7318https://curecurrent.com/trials/gestational-diabetes-mellitus-and-cardiovascular-disease-the-role-of-vascular-dysfunction-7319https://curecurrent.com/trials/gestational-diabetes-mellitus-and-implications-for-cardiovascular-disease-risk-7320https://curecurrent.com/trials/evaluate-the-efficacy-and-safety-of-once-daily-administration-of-atrasentan-tablets-low-and-high-compared-to-placebo-in-7321https://curecurrent.com/trials/myocardial-function-ffa-metabolism-in-hiv-metabolic-syndrome-7322https://curecurrent.com/trials/a-comparison-of-two-initial-dosing-formulas-7323https://curecurrent.com/trials/cgm-evaluation-of-glucose-excursions-in-basal-insulin-treated-t2dm-at-fasting-glucose-target-7324https://curecurrent.com/trials/diabetes-mellitus-type-2-basal-insulin-dosing-requirements-study-7325https://curecurrent.com/trials/a-randomized-double-blind-placebo-controlled-study-to-assess-the-safety-and-efficacy-of-krp-104-in-patients-with-type-2-7326https://curecurrent.com/trials/endothelial-function-in-young-hispanic-adults-at-risk-for-type-2-diabetes-7327https://curecurrent.com/trials/thiamine-and-acute-decompensated-heart-failure-pilot-study-7328https://curecurrent.com/trials/avoiding-diabetes-after-pregnancy-trial-7329https://curecurrent.com/trials/characterization-of-the-variability-of-insulin-secretory-parameters-in-the-meal-tolerance-and-the-maximal-stimulation-te-7330https://curecurrent.com/trials/an-efficacy-safety-and-tolerability-study-of-canagliflozin-in-patients-with-type-2-diabetes-mellitus-who-have-moderate-r-7331https://curecurrent.com/trials/patient-preference-and-satisfaction-with-insulin-glargine-lantus-solostar-pen-vs-conventional-vial-syringe-method-of-lan-7332https://curecurrent.com/trials/biomarkers-of-metabolic-syndrome-and-prediabetes-7333https://curecurrent.com/trials/study-of-safety-and-efficacy-of-pf-04991532-in-subjects-with-type-2-diabetes-mellitus-7334https://curecurrent.com/trials/lancet-blood-volume-comparison-study-7335https://curecurrent.com/trials/the-characterization-of-blood-volumes-of-commercially-available-lancing-devices-7336https://curecurrent.com/trials/diabetes-connect-patients-and-providers-use-of-a-secure-website-for-blood-glucose-monitoring-in-type-2-diabetes-7337https://curecurrent.com/trials/safety-and-efficacy-study-of-jtt-851-in-patients-with-type-2-diabetes-mellitus-7338https://curecurrent.com/trials/metformin-use-and-vitamin-b12-deficiency-7339https://curecurrent.com/trials/efficacy-of-inhaled-cannabis-in-diabetic-painful-peripheral-neuropathy-7340https://curecurrent.com/trials/the-cantata-d-trial-canagliflozin-treatment-and-trial-analysis-dpp-4-inhibitor-comparator-trial-7341https://curecurrent.com/trials/pharmacokinetic-and-pharmacodynamic-properties-of-biod-105-and-biod-107-compared-to-humalog-in-subjects-with-type-1-diab-7342https://curecurrent.com/trials/pilot-study-of-the-effects-of-erythritol-on-endothelial-function-in-patients-with-type-2-diabetes-mellitus-7343https://curecurrent.com/trials/navigator-ii-continuous-glucose-monitor-home-use-study-7344https://curecurrent.com/trials/effects-of-rosiglitazone-on-the-metabolic-phenotype-of-impaired-glucose-tolerance-in-youth-7345https://curecurrent.com/trials/a-study-in-patients-with-neuropathic-pain-from-diabetic-peripheral-neuropathy-dpn-7346https://curecurrent.com/trials/an-efficacy-safety-and-tolerability-study-of-canagliflozin-jnj-28431754-in-patients-with-type-2-diabetes-7347https://curecurrent.com/trials/family-pals-partners-in-lifestyle-support-7348https://curecurrent.com/trials/prontosan-versus-saline-in-the-cleansing-of-chronic-leg-ulcers-in-diabetic-patients-7349https://curecurrent.com/trials/vascular-effects-of-rosiglitazone-versus-glyburide-in-type-2-diabetic-patients-7350https://curecurrent.com/trials/the-cantata-mp-trial-canagliflozin-treatment-and-trial-analysis-metformin-and-pioglitazone-7351https://curecurrent.com/trials/vitamin-d-for-improving-metabolic-control-and-depressive-symptoms-7352https://curecurrent.com/trials/ankle-equinus-contracture-treated-with-dynamic-splinting-7353https://curecurrent.com/trials/lifestyle-intervention-to-improve-insulin-sensitivity-and-markers-of-cardiovascular-risk-in-prostate-cancer-survivors-7354https://curecurrent.com/trials/swab-sample-collection-for-the-detection-of-bacterial-proteases-7355https://curecurrent.com/trials/woundchek-protease-status-point-of-care-poc-diagnostic-test-on-dfu-7356https://curecurrent.com/trials/exercise-and-nerve-function-in-diabetes-7357https://curecurrent.com/trials/pilot-study-to-assess-pre-packaged-portion-controlled-meal-plan-on-weight-loss-7358https://curecurrent.com/trials/the-effects-of-a-pre-packaged-portion-controlled-meal-plan-on-type-2-diabetes-and-glycemic-control-a-comparison-study-7359https://curecurrent.com/trials/secretin-chirhostim-pancreas-perfusion-for-pancreatic-adenocarcinoma-7360https://curecurrent.com/trials/a-trial-of-tt223-in-patients-with-type-2-diabetes-who-are-taking-metformin-and-or-thiazolidinedione-7361https://curecurrent.com/trials/the-cantata-msu-trial-canagliflozin-treatment-and-trial-analysis-metformin-and-sulphonylurea-7362https://curecurrent.com/trials/alpha-lipoic-acid-and-insulin-resistance-7363https://curecurrent.com/trials/trial-to-examine-text-message-based-mhealth-in-emergency-department-patients-with-diabetes-7364https://curecurrent.com/trials/comparative-study-of-1000-centistoke-versus-5000-centistoke-silicone-oil-for-repair-of-complex-retinal-detachments-7365https://curecurrent.com/trials/vitamin-d-in-minorities-with-prediabetes-7366https://curecurrent.com/trials/magnesium-supplementation-in-the-second-trimester-of-pregnancy-to-overweight-and-obese-individuals-7367https://curecurrent.com/trials/addressing-the-role-of-nutrition-education-health-literacy-in-diabetes-care-7368https://curecurrent.com/trials/comparison-of-nodat-in-kidney-transplant-patients-receiving-belatacept-versus-standard-immunosuppression-7369https://curecurrent.com/trials/urine-ph-as-a-predictor-of-diabetes-7370https://curecurrent.com/trials/insulin-receptor-substrate-1-irs-1-regulation-in-insulin-resistance-7371https://curecurrent.com/trials/enzymatic-versus-vs-autolytic-debridement-of-diabetic-foot-ulcers-7372https://curecurrent.com/trials/adrenocorticotropic-hormone-acth-treatment-of-nephrotic-range-proteinuria-in-diabetic-nephropathy-nrdn-7373https://curecurrent.com/trials/food-rheology-and-feeding-in-lean-and-obese-humans-7374https://curecurrent.com/trials/wound-edge-changes-following-treatment-with-santyl-7375https://curecurrent.com/trials/a-pharmacokinetic-and-pharmacodynamic-study-to-determine-blood-levels-of-jnj-28431754-canagliflozin-in-patients-with-typ-7376https://curecurrent.com/trials/a-safety-tolerability-pharmacokinetics-and-pharmacodynamics-study-of-jnj-28431754-in-patients-with-type-2-diabetes-melli-7377https://curecurrent.com/trials/associated-factors-in-perioperative-hypoglycemia-in-patients-with-diabetes-7378https://curecurrent.com/trials/a-two-part-single-ascending-dose-study-to-assess-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-ds-730-7379https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-canagliflozin-jnj-28431754-in-promoting-weight-loss-in-overweight-and-obese-p-7380https://curecurrent.com/trials/efficacy-and-safety-of-alogliptin-compared-to-glipizide-in-elderly-diabetics-7381https://curecurrent.com/trials/a-healthy-volunteer-study-to-assess-relative-bioavailability-of-powder-in-capsule-and-a-tablet-formulation-and-the-effec-7382https://curecurrent.com/trials/phase-1-2a-randomized-double-blind-placebo-controlled-study-to-assess-safety-tolerability-pk-and-pd-response-of-pb1023-i-7383https://curecurrent.com/trials/reducing-disparities-in-diabetes-risk-through-lifestyle-changes-in-community-settings-7384https://curecurrent.com/trials/open-label-4-week-study-of-itca-650-in-adults-with-type-2-diabetes-7385https://curecurrent.com/trials/harnessing-health-it-for-self-management-support-and-medication-activation-in-a-medicaid-health-plan-7386https://curecurrent.com/trials/adjustable-gastric-banding-and-its-effects-on-postprandial-glucose-metabolism-independent-of-weight-loss-7387https://curecurrent.com/trials/tu-salud-si-cuenta-media-campaign-7388https://curecurrent.com/trials/tu-salud-si-cuenta-ut-community-outreach-program-for-community-based-diabetes-prevention-and-control-7389https://curecurrent.com/trials/calcineurin-inhibitor-free-steroid-free-immunosuppressive-regimen-in-simultaneous-islet-kidney-transplantation-for-uremi-7390https://curecurrent.com/trials/a-study-to-look-at-the-effects-of-four-weeks-of-treatment-on-the-healing-of-diabetic-foot-ulcers-7391https://curecurrent.com/trials/a-placebo-controlled-safety-and-efficacy-study-of-msdc-0160-in-type-2-diabetes-with-active-comparator-7392https://curecurrent.com/trials/a-national-study-of-the-chronic-disease-self-management-program-7393https://curecurrent.com/trials/ranibizumab-as-a-rescue-therapy-for-diabetic-macular-edema-7394https://curecurrent.com/trials/a-family-based-intervention-to-reduce-the-risk-of-type-2-diabetes-in-children-7395https://curecurrent.com/trials/islet-transplantation-for-type-1-diabetes-mellitus-7396https://curecurrent.com/trials/affects-of-once-daily-oral-administration-of-tzp-102-on-the-treatment-of-symptoms-associated-with-diabetic-gastroparesis-7397https://curecurrent.com/trials/study-of-safety-and-efficacy-of-pf-04991532-in-subjects-with-type-2-diabetes-7398https://curecurrent.com/trials/investigate-effect-of-amg-151-on-24-hour-ambulatory-blood-pressure-glucose-levels-in-type-2-diabetes-mellitus-subjects-7399https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-jnj-28431754-canagliflozin-on-post-meal-glucose-in-patients-with-type-2-diabetes-melli-7400https://curecurrent.com/trials/internet-diabetes-self-management-workshop-7401https://curecurrent.com/trials/physical-activity-in-overweight-girls-implications-for-reversing-risk-factors-for-type-2-diabetes-7402https://curecurrent.com/trials/adiponectin-and-ethnic-differences-in-insulin-resistance-7403https://curecurrent.com/trials/pharmacokinetic-safety-tolerability-study-of-a-single-sc-dose-of-pb1023-injection-in-subjects-with-normal-and-impaired-r-7404https://curecurrent.com/trials/ghrelin-effect-on-beta-cell-function-in-health-and-disease-7405https://curecurrent.com/trials/single-dose-safety-tolerability-pharmacokinetics-and-pharmacodynamics-study-of-pf-06291874-in-healthy-adult-subjects-7406https://curecurrent.com/trials/cord-blood-plus-vitamin-d-and-omega-3s-in-t1d-7407https://curecurrent.com/trials/evaluating-the-effects-of-a-diet-and-exercise-program-in-people-with-type-2-diabetes-or-prediabetes-the-shape3-study-7408https://curecurrent.com/trials/efficacy-and-safety-of-alogliptin-combined-with-pioglitazone-in-treating-subjects-with-type-2-diabetes-mellitus-7409https://curecurrent.com/trials/safety-and-efficacy-of-ho-03-03-10-g-in-the-treatment-of-plantar-neuropathic-diabetic-foot-ulcers-7410https://curecurrent.com/trials/efficacy-of-alogliptin-and-pioglitazone-in-subjects-with-type-2-diabetes-mellitus-7411https://curecurrent.com/trials/efficacy-of-alogliptin-with-pioglitazone-actos-in-subjects-with-type-2-diabetes-mellitus-7412https://curecurrent.com/trials/dance-dance-revolution-ddr-in-type-2-diabetes-7413https://curecurrent.com/trials/a-clinical-study-of-the-c8-medisensors-optical-glucose-monitor-7414https://curecurrent.com/trials/efficacy-and-safety-of-alogliptin-plus-metformin-in-patients-with-type-2-diabetes-7415https://curecurrent.com/trials/long-term-safety-of-alogliptin-in-patients-with-type-2-diabetes-mellitus-7416https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-the-combination-of-valturna-and-amlodipine-or-valturna-and-chlorthalidone-v-7417https://curecurrent.com/trials/problem-solving-and-cardiovascular-disease-risk-management-in-diabetic-blacks-7418https://curecurrent.com/trials/the-dine-study-diet-intervention-to-negate-diabetes-study-improving-weight-loss-outcomes-for-african-americans-7419https://curecurrent.com/trials/bone-health-in-type-1-diabetes-7420https://curecurrent.com/trials/safety-and-efficacy-study-of-vitrase-for-clearance-of-severe-vitreous-hemorrhage-7421https://curecurrent.com/trials/assessment-of-intravitreous-injections-of-vitrase-for-inducing-posterior-vitreous-detachment-7422https://curecurrent.com/trials/blood-sugar-take-care-and-glucose-metabolism-7423https://curecurrent.com/trials/the-effects-of-anti-inflammatory-treatment-on-insulin-resistance-in-healthy-volunteers-7424https://curecurrent.com/trials/non-invasive-measurement-of-microvascular-blood-flow-during-mild-external-compression-of-the-leg-7425https://curecurrent.com/trials/proteus-sustained-behavior-change-study-7426https://curecurrent.com/trials/safety-and-pharmacokinetics-of-cbx129801-in-patients-with-type-1-diabetes-7427https://curecurrent.com/trials/the-impact-of-actos-treatment-of-diabetes-on-glucose-transporters-in-muscle-7428https://curecurrent.com/trials/blood-glucose-testing-and-you-7429https://curecurrent.com/trials/impact-of-an-automated-telephone-intervention-on-glycosylated-hemoglobin-hba1c-in-type-2-diabetes-7430https://curecurrent.com/trials/effect-of-paricalcitol-zemplar-on-endothelial-function-and-inflammation-in-type-2-diabetes-and-chronic-kidney-disease-7431https://curecurrent.com/trials/single-ascending-dose-trial-in-patients-with-type-2-diabetes-7432https://curecurrent.com/trials/improving-diabetes-efforts-across-language-and-literacy-ideall-7433https://curecurrent.com/trials/evaluation-of-glycemic-control-using-adjunctive-continuous-glucose-monitoring-with-the-dexcom-g4-system-7434https://curecurrent.com/trials/examining-macrophage-influx-and-vascularization-in-chronic-pancreatitis-7435https://curecurrent.com/trials/effectiveness-and-safety-of-the-dexcom-g4-continuous-glucose-monitoring-system-in-pediatric-subjects-with-diabetes-melli-7436https://curecurrent.com/trials/use-of-campath-for-induction-and-maintenance-therapy-in-pancreas-after-kidney-transplantation-7437https://curecurrent.com/trials/how-glargine-insulin-oral-diabetes-medications-and-exenatide-may-improve-blood-sugar-control-and-weight-gain-in-type-2-d-7438https://curecurrent.com/trials/impact-of-gbs-on-cvd-in-type-2-diabetes-mellitus-7439https://curecurrent.com/trials/efficacy-and-safety-study-of-jtt-654-in-type-2-diabetic-patients-7440https://curecurrent.com/trials/a-placebo-controlled-cross-over-trial-of-aripiprazole-7441https://curecurrent.com/trials/safety-and-efficacy-study-of-jtt-130-in-obese-type-2-diabetic-patients-7442https://curecurrent.com/trials/the-origin-trial-outcome-reduction-with-initial-glargine-intervention-7443https://curecurrent.com/trials/comparative-glucose-clamp-study-of-wockhardt-s-recombinant-insulin-analog-glargine-glaritus-with-lantus-in-t1dm-7444https://curecurrent.com/trials/comparison-of-technosphere-insulin-inhalation-powder-subcutaneous-rapid-acting-analog-in-subjects-with-type-1-diabetes-7445https://curecurrent.com/trials/multicenter-worksite-nutrition-study-7446https://curecurrent.com/trials/safety-and-efficacy-study-in-subjects-with-diabetic-neuropathic-pain-7447https://curecurrent.com/trials/common-genetic-variation-and-type-2-diabetes-7448https://curecurrent.com/trials/exercise-training-in-type-2-diabetes-and-hypertension-7449https://curecurrent.com/trials/evaluation-of-the-impact-of-training-on-outcome-measures-in-subjects-with-painful-diabetic-neuropathy-7450https://curecurrent.com/trials/the-effects-of-co-admin-of-colesevelam-and-sitagliptin-on-glucose-metabolism-in-subjects-with-type-2-diabetes-mellitus-7451https://curecurrent.com/trials/blood-glucose-awareness-training-for-parents-7452https://curecurrent.com/trials/early-intervention-for-gestational-diabetes-7453https://curecurrent.com/trials/a-pilot-study-of-continuous-subcutaneous-pramlintide-infusion-therapy-in-patients-with-type-1-diabetes-7454https://curecurrent.com/trials/point-of-service-diabetes-screening-evaluation-7455https://curecurrent.com/trials/the-effect-of-non-surgical-periodontal-therapy-on-glycemic-control-and-bacterial-levels-in-a-mexican-american-population-7456https://curecurrent.com/trials/bias-source-of-signal-in-scout-ds-7457https://curecurrent.com/trials/customer-support-response-study-7458https://curecurrent.com/trials/a-12-week-study-in-patients-with-type-2-diabetes-mellitus-t2dm-7459https://curecurrent.com/trials/a-multicenter-study-comparing-the-analgesic-effects-and-safety-of-abt-639-compared-to-placebo-in-subjects-with-diabetic-7460https://curecurrent.com/trials/novel-therapy-to-preserve-beta-cell-function-in-new-onset-type-1-diabetes-7461https://curecurrent.com/trials/multiple-dose-safety-toelrability-pharmacokinetics-and-midazolam-interaction-in-healthy-overweight-and-obese-subjects-7462https://curecurrent.com/trials/comparative-glucose-clamp-study-of-wockhardt-s-human-isophane-insulin-with-novolin-n-in-healthy-subjects-7463https://curecurrent.com/trials/comparative-glucose-clamp-study-of-wockhardt-s-insulin-human-regular-for-injection-and-actrapid-in-type-1-diabetics-7464https://curecurrent.com/trials/comparative-glucose-clamp-study-of-wockhardt-s-insulin-human-regular-for-injection-and-actrapid-in-healthy-subjects-7465https://curecurrent.com/trials/comparative-wockhardt-s-glucose-clamp-study-human-isophane-susp-30iu-ml-70iu-ml-with-novolin70-30-in-healthy-subjects-7466https://curecurrent.com/trials/comparative-glucose-clamp-study-of-wockhardt-s-insulin-human-regular-for-injection-and-novolin-r-in-healthy-subjects-7467https://curecurrent.com/trials/a-study-to-evaluate-itca-650-compared-to-glimepiride-for-the-treatment-of-type-2-diabetes-7468https://curecurrent.com/trials/a-study-to-evaluate-itca-650-compared-to-glimepiride-as-add-on-therapy-for-the-treatment-of-type-2-diabetes-7469https://curecurrent.com/trials/a-study-to-evaluate-itca-650-compared-to-sitagliptin-for-the-treatment-of-type-2-diabetes-7470https://curecurrent.com/trials/do-home-monitors-improve-blood-pressure-control-7471https://curecurrent.com/trials/diabetes-prevention-in-women-with-a-recent-history-of-gestational-diabetes-mellitus-gdm-7472https://curecurrent.com/trials/effect-of-gaba-supplementation-in-the-progression-of-type-1-diabetes-in-children-7473https://curecurrent.com/trials/roux-en-y-gastric-bypass-vs-lifestyle-modification-and-medical-therapy-in-the-treatment-of-type-2-diabetes-7474https://curecurrent.com/trials/swab-sample-collection-for-the-detection-of-bacterial-proteases-in-wounds-assay-7475https://curecurrent.com/trials/diabetic-gastroparesis-efficacy-safety-study-of-tzp-102-7476https://curecurrent.com/trials/acute-impact-of-intramuscular-im-aripiprazole-and-olanzapine-on-insulin-resistance-in-high-risk-prediabetics-7477https://curecurrent.com/trials/treating-nonalcoholic-steatohepatitis-with-pioglitazone-7478https://curecurrent.com/trials/safety-and-efficacy-of-xenical-in-children-and-adolescents-with-obesity-related-diseases-7479https://curecurrent.com/trials/outreach-for-diabetes-cure-7480https://curecurrent.com/trials/understanding-of-genetic-risk-information-for-type-2-diabetes-7481https://curecurrent.com/trials/impact-of-diabetes-on-left-ventricular-remodeling-7482https://curecurrent.com/trials/flavonoids-in-the-treatment-of-endothelial-dysfunction-in-children-with-diabetes-7483https://curecurrent.com/trials/clinical-decision-support-for-medication-management-and-adherence-7484https://curecurrent.com/trials/safety-and-efficacy-of-once-daily-oral-administrations-of-tzp-102-for-gastroparesis-in-patients-with-diabetes-mellitus-7485https://curecurrent.com/trials/evaluation-and-comparison-of-noninvasive-blood-glucose-concentrations-7486https://curecurrent.com/trials/safety-and-efficacy-of-iv-infusion-of-investigational-agent-tzp-101-in-patients-with-severe-diabetic-gastroparesis-7487https://curecurrent.com/trials/pulmonary-function-substudy-for-subjects-enrolled-in-studies-mkc-ti-161-mkc-ti-162-or-mkc-ti-166-7488https://curecurrent.com/trials/aliskiren-and-valsartan-vs-valsartan-alone-in-patients-with-stage-ii-systolic-hypertension-and-type-ii-diabetes-mellitus-7489https://curecurrent.com/trials/safety-and-tolerability-after-four-weeks-of-treatment-with-azd1656-in-patients-with-type-2-diabetes-7490https://curecurrent.com/trials/evaluation-of-scout-ds-in-subjects-with-type-2-diabetes-2-7491https://curecurrent.com/trials/evaluation-of-low-source-of-signal-in-scout-ds-7492https://curecurrent.com/trials/evaluation-of-a-noninvasive-diabetes-screening-device-in-subjects-at-risk-for-diabetes-7493https://curecurrent.com/trials/noninvasive-screening-for-early-evidence-of-diabetes-with-scout-ds-7494https://curecurrent.com/trials/evaluation-of-scout-ds-in-subjects-with-type-2-diabetes-7495https://curecurrent.com/trials/screening-for-early-evidence-of-diabetes-7496https://curecurrent.com/trials/real-time-adaptation-to-changes-in-insulin-sensitivity-7497https://curecurrent.com/trials/temporary-gastric-electrical-stimulation-for-drug-refractory-gastroparesis-7498https://curecurrent.com/trials/perioperative-insulin-glargine-dosing-study-7499https://curecurrent.com/trials/use-of-pyridostigmine-for-constipation-in-diabetics-7500https://curecurrent.com/trials/improving-diabetes-risk-factors-in-persons-with-schizophrenia-or-bipolar-disorder-by-switching-to-ziprasidone-7501https://curecurrent.com/trials/timing-of-pre-meal-insulin-versus-accurate-carbohydrate-counting-in-youth-with-type-1-diabetes-7502https://curecurrent.com/trials/using-learning-teams-for-reflective-adaptation-for-diabetes-and-depression-7503https://curecurrent.com/trials/santyl-vs-sharp-debridement-of-diabetic-foot-wounds-7504https://curecurrent.com/trials/a-trial-of-meal-replacement-at-a-community-diabetes-clinic-serving-a-low-socioeconomic-hispanic-population-7505https://curecurrent.com/trials/study-to-assess-the-safety-and-tolerability-after-multiple-oral-doses-of-azd1656-in-patients-with-type-2-diabetes-mellit-7506https://curecurrent.com/trials/study-of-metamucil-on-blood-glucose-and-hba1c-in-type-ii-niddm-subjects-7507https://curecurrent.com/trials/improving-diabetes-after-bariatric-surgery-7508https://curecurrent.com/trials/hospital-management-of-hyperglycemia-study-of-insulin-glargine-plus-insulin-lispro-versus-human-regular-insulin-7509https://curecurrent.com/trials/centella-asiatica-selected-triterpenes-cast-for-diabetic-neuropathy-7510https://curecurrent.com/trials/study-to-evaluate-the-analgesic-efficacy-of-28-days-oral-administration-of-azd2066-compared-with-placebo-in-patients-wit-7511https://curecurrent.com/trials/production-of-free-fatty-acids-from-blood-triglycerides-7512https://curecurrent.com/trials/a-trial-in-diabetic-patients-to-assess-effect-of-ce-326-597-on-glucose-control-and-body-weight-7513https://curecurrent.com/trials/a-1-year-study-on-the-effects-of-cp-945-598-for-the-treatment-of-obesity-in-overweight-type-2-diabetic-patients-7514https://curecurrent.com/trials/an-inpatient-evaluation-of-six-day-subcutaneous-glucose-sensor-performance-7515https://curecurrent.com/trials/physical-activity-in-youth-implications-for-reversing-risk-factors-for-type-2-diabetes-7516https://curecurrent.com/trials/a-multiple-dose-study-of-pf-04620110-in-type-2-diabetes-patients-7517https://curecurrent.com/trials/stem-cell-mobilization-in-diabetic-neuropathy-subjects-receiving-sb-509-7518https://curecurrent.com/trials/clinical-trial-of-sb-509-in-subjects-with-diabetic-neuropathy-7519https://curecurrent.com/trials/clinical-trial-of-sb-509-in-subjects-with-diabetic-neuropathy-7520https://curecurrent.com/trials/evaluate-the-safety-and-tolerability-of-incb019602-when-administered-with-metformin-in-patients-with-type-2-diabetes-7521https://curecurrent.com/trials/ccrc-understanding-the-effects-of-omega-3-fatty-acids-versus-lignans-in-flaxseed-on-metabolic-and-inflammatory-markers-l-7522https://curecurrent.com/trials/yield-and-safety-of-colonoscopy-in-patients-older-than-80-years-7523https://curecurrent.com/trials/effect-of-a-fibrate-and-a-statin-on-endothelial-dysfunction-7524https://curecurrent.com/trials/macular-edema-incidence-severity-reduction-with-nevanac-7525https://curecurrent.com/trials/follow-up-study-for-exubera-7526https://curecurrent.com/trials/using-conversation-maps-to-reinforce-self-care-7527https://curecurrent.com/trials/va-diabetes-prevention-epidemiology-of-pre-diabetes-and-implementation-pilot-7528https://curecurrent.com/trials/mechanisms-of-glucose-lowering-effect-of-colesevelam-hcl-7529https://curecurrent.com/trials/study-evaluating-efficacy-and-safety-of-pf-04523655-versus-laser-in-subjects-with-diabetic-macular-edema-7530https://curecurrent.com/trials/a-phase-ii-study-to-evaluate-the-effects-of-oral-ono-5129-in-type-2-diabetes-mellitus-7531https://curecurrent.com/trials/a-phase-iii-study-to-investigate-the-impact-of-diamyd-in-patients-newly-diagnosed-with-type-1-diabetes-usa-diaprevent-7532https://curecurrent.com/trials/fluid-resuscitation-for-pediatric-diabetic-ketoacidosis-7533https://curecurrent.com/trials/intensive-glycemic-control-and-skeletal-health-study-7534https://curecurrent.com/trials/evaluation-of-insulin-glargine-in-combination-with-sitagliptin-in-type-2-diabetes-patients-easie-extension-trial-7535https://curecurrent.com/trials/does-flaxseed-supplementation-improve-glycemic-control-in-individuals-with-pre-diabetes-7536https://curecurrent.com/trials/effects-of-a-food-preservative-on-glucose-homeostasis-7537https://curecurrent.com/trials/pharmacokinetic-profile-of-two-formulations-of-pb1023-following-single-subcutaneous-injection-in-subjects-with-type-2-di-7538https://curecurrent.com/trials/safety-and-efficacy-study-of-dsc127-in-treating-subjects-with-diabetic-ulcers-7539https://curecurrent.com/trials/progression-of-diabetic-retinopathy-post-bariatric-surgery-bs-7540https://curecurrent.com/trials/timing-of-meal-insulin-boluses-for-optimal-postprandial-glycemic-control-in-type-1-diabetes-7541https://curecurrent.com/trials/virtual-world-health-behavior-counseling-for-patients-with-diabetes-7542https://curecurrent.com/trials/study-assessing-an-insulin-pump-controlling-algorithm-to-minimize-hypo-and-hyper-in-type-1-during-crc-setting-7543https://curecurrent.com/trials/cerebral-edema-in-pediatric-diabetic-ketoacidosis-7544https://curecurrent.com/trials/the-diabetes-telemonitoring-diatel-study-7545https://curecurrent.com/trials/tak-875-glimepiride-drug-interaction-study-7546https://curecurrent.com/trials/ramelteon-as-an-adjunct-therapy-in-non-diabetic-patients-with-schizophrenia-7547https://curecurrent.com/trials/evaluation-of-lifestyle-interventions-to-treat-elevated-cardiometabolic-risk-in-primary-care-7548https://curecurrent.com/trials/study-of-vi-0521-compared-to-placebo-in-the-glycemic-management-of-obese-diabetics-7549https://curecurrent.com/trials/evaluation-of-insulin-glargine-versus-sitagliptin-in-insulin-naive-patients-7550https://curecurrent.com/trials/open-label-study-to-evaluate-the-long-term-safety-and-efficacy-of-vi-0521-in-type-2-diabetic-adults-7551https://curecurrent.com/trials/study-of-vi-0521-compared-to-placebo-in-treatment-of-diabetes-and-obesity-in-adults-with-obesity-related-co-morbid-condi-7552https://curecurrent.com/trials/a-vi-0521-study-to-evaluate-the-long-term-safety-and-efficacy-in-type-2-diabetic-adults-7553https://curecurrent.com/trials/acz885-in-type-1-diabetes-mellitus-7554https://curecurrent.com/trials/mobile-health-technology-as-an-intervention-for-diabetes-self-management-7555https://curecurrent.com/trials/reducing-clinical-inertia-in-diabetes-care-7556https://curecurrent.com/trials/effect-of-calcium-polycarbophil-on-type-ii-diabetes-mellitus-control-a-randomized-double-blind-study-7557https://curecurrent.com/trials/chromium-and-insulin-resistance-7558https://curecurrent.com/trials/a-safety-study-of-arry-403-in-patients-with-type-2-diabetes-7559https://curecurrent.com/trials/diabetic-educational-eating-plan-7560https://curecurrent.com/trials/a-clinical-study-to-evaluate-renal-hemodynamic-responses-to-aliskiren-in-patients-with-type-2-diabetes-mellitus-7561https://curecurrent.com/trials/nutrient-timing-following-resistance-exercise-7562https://curecurrent.com/trials/automated-sms-based-appointment-validation-tool-7563https://curecurrent.com/trials/pilot-study-to-assess-adherence-to-a-novel-eating-system-in-men-and-women-with-type-2-diabetes-mellitus-7564https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-tolerability-of-abt-614-and-its-effect-on-kidney-function-in-subjects-with-type-2-dia-7565https://curecurrent.com/trials/pilot-project-of-health-promotion-for-people-with-diabetes-7566https://curecurrent.com/trials/anti-tac-for-treatment-of-leukemia-7567https://curecurrent.com/trials/pace-idp-an-intervention-for-youth-at-risk-for-diabetes-7568https://curecurrent.com/trials/subcutaneous-aspart-insulin-to-treat-diabetic-ketoacidosis-dka-and-beta-hydroxybutyrate-testing-in-dka-7569https://curecurrent.com/trials/characterization-of-the-variability-of-insulin-secretory-parameters-in-the-meal-tolerance-and-the-maximal-stimulation-te-7570https://curecurrent.com/trials/impact-of-mulberry-leaf-on-type-2-diabetes-7571https://curecurrent.com/trials/plant-based-dietary-intervention-in-type-2-diabetes-7572https://curecurrent.com/trials/worksite-nutrition-study-7573https://curecurrent.com/trials/inv-144-versus-losartan-in-hypertension-and-type-2-diabetes-mellitus-patients-with-macroalbuminuria-7574https://curecurrent.com/trials/fast-food-study-assessment-of-the-effects-of-fast-food-on-inflammatory-markers-7575https://curecurrent.com/trials/androgen-deprivation-therapy-study-7576https://curecurrent.com/trials/hokt3-1-ala-ala-combined-with-sirolimus-and-delayed-tacrolimus-in-type-1-diabetic-islet-allograft-recipients-7577https://curecurrent.com/trials/the-microvascular-complications-study-7578https://curecurrent.com/trials/stress-dietary-lapse-and-weight-loss-among-adults-with-type-2-diabetes-7579https://curecurrent.com/trials/delayed-mycophenolate-mofetil-in-single-donor-islet-allotransplantation-in-type-1-diabetes-7580https://curecurrent.com/trials/cv-disease-in-adolescents-with-type-2-diabetes-7581https://curecurrent.com/trials/step-social-support-to-empower-parents-7582https://curecurrent.com/trials/administrative-claims-analysis-of-metanx-in-diabetic-peripheral-neuropathy-7583https://curecurrent.com/trials/positron-emission-tomography-pet-imaging-of-pancreatic-beta-cell-mass-in-healthy-and-type-1-diabetic-patients-7584https://curecurrent.com/trials/assessing-barriers-to-ada-guideline-adherence-7585https://curecurrent.com/trials/metanx-effects-on-nerve-fiber-density-in-neuropathic-diabetics-7586https://curecurrent.com/trials/single-cohort-2-period-study-to-assess-pharmacokinetics-of-metformin-alone-and-in-combination-with-ranolazine-500-mg-7587https://curecurrent.com/trials/single-cohort-4-period-study-to-assess-pharmacokinetics-of-metformin-alone-and-in-combination-with-ranolazine-7588https://curecurrent.com/trials/metabolic-effects-of-alcohol-7589https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-pf-05175157-in-healthy-volunteers-7590https://curecurrent.com/trials/the-abc-planning-study-diabetes-and-cardiovascular-risks-in-primary-care-7591https://curecurrent.com/trials/6-month-comparison-of-morning-lantus-versus-neutral-protamine-hagedorn-insulin-in-young-children-with-type-1-diabetes-7592https://curecurrent.com/trials/automated-telephone-nutrition-support-7593https://curecurrent.com/trials/human-atherosclerotic-plaque-inflammation-imaged-using-pdg-pet-ct-7594https://curecurrent.com/trials/the-efficacy-and-treatment-adherence-with-an-integrated-program-on-hba1c-scores-in-patients-with-type-2-diabetes-7595https://curecurrent.com/trials/effects-of-peanut-and-peanut-butter-consumption-on-blood-lipids-and-glycemic-control-in-adults-with-type-2-diabetes-7596https://curecurrent.com/trials/fall-risk-assessment-in-people-with-diabetic-neuropathy-7597https://curecurrent.com/trials/randomized-crossover-study-of-magnesium-supplementation-7598https://curecurrent.com/trials/hyperglycemia-and-oxidative-stress-in-the-human-brain-with-diabetes-7599https://curecurrent.com/trials/we-can-prevent-diabetes-a-behavioral-intervention-to-reduce-diabetes-risk-in-african-americans-7600https://curecurrent.com/trials/picturerx-an-intervention-to-reduce-latino-health-disparities-7601https://curecurrent.com/trials/periprocedural-glycemic-control-in-patients-undergoing-coronary-angiography-7602https://curecurrent.com/trials/a-multiple-ascending-dose-study-of-cat-1004-in-patients-with-type-2-diabetes-7603https://curecurrent.com/trials/a-study-of-the-effects-of-ketoconazole-taken-orally-has-on-the-pk-profiles-of-a-dose-of-gsk189075-in-healthy-volunteers-7604https://curecurrent.com/trials/a-study-of-the-effects-of-gsk189075-on-pk-profiles-of-an-oral-contraceptive-pill-when-given-to-healthy-female-volunteers-7605https://curecurrent.com/trials/a-study-to-compare-the-safety-and-drug-levels-in-blood-when-using-various-forms-of-gsk189075-given-to-healthy-subjects-7606https://curecurrent.com/trials/a-study-to-assess-gw677954-used-in-combination-with-insulin-in-subjects-who-have-type-2-diabetes-mellitus-7607https://curecurrent.com/trials/a-study-to-evaluate-and-study-drug-levels-in-blood-plasma-when-giving-high-doses-of-gsk189075-to-healthy-volunteers-7608https://curecurrent.com/trials/a-single-dose-of-gsk189075-taken-by-mouth-containing-small-amounts-of-radioactivity-studied-in-healthy-male-volunteers-7609https://curecurrent.com/trials/safety-and-efficacy-study-of-mre0094-to-treat-chronic-neuropathic-diabetic-foot-ulcers-7610https://curecurrent.com/trials/safety-and-efficacy-study-of-mre0094-to-treat-large-single-or-multiple-chronic-neuropathic-diabetic-foot-ulcers-7611https://curecurrent.com/trials/lifestyle-modification-for-type-2-diabetes-prevention-in-overweight-youth-7612https://curecurrent.com/trials/research-on-the-nature-diagnosis-and-treatment-of-obesity-and-diabetes-7613https://curecurrent.com/trials/molecular-mechanisms-of-type-2-diabetes-mellitus-7614https://curecurrent.com/trials/effect-of-pioglitazone-on-the-course-of-new-onset-type-1-diabetes-mellitus-7615https://curecurrent.com/trials/a-study-for-treatment-of-pain-in-patients-with-diabetic-neuropathy-7616https://curecurrent.com/trials/a-pilot-study-to-improve-patient-doctor-communication-7617https://curecurrent.com/trials/the-relative-prevalence-and-severity-of-autonomic-nervous-system-dysfunction-7618https://curecurrent.com/trials/developing-and-implementing-a-quality-measure-for-glycemic-control-7619https://curecurrent.com/trials/efficacy-of-lapaquistat-acetate-in-subjects-currently-treated-with-lipid-lowering-therapy-7620https://curecurrent.com/trials/the-mi-heart-project-7621https://curecurrent.com/trials/a-study-of-pf-05190457-in-healthy-volunteers-and-type-2-diabetic-patients-7622https://curecurrent.com/trials/a-study-to-evaluate-pf-05175157-in-healthy-volunteers-7623https://curecurrent.com/trials/extension-to-a-study-on-the-efficacy-and-safety-of-vildagliptin-compared-to-rosiglitazone-in-drug-naive-patients-with-ty-7624https://curecurrent.com/trials/efficacy-and-safety-of-vildagliptin-in-subjects-with-impaired-glucose-tolerance-7625https://curecurrent.com/trials/a-study-to-assess-the-effects-of-vildagliptin-on-gastric-emptying-in-patients-with-type-2-diabetes-7626https://curecurrent.com/trials/efficacy-and-safety-of-vildagliptin-in-combination-with-glimepiride-in-patients-with-type-2-diabetes-7627https://curecurrent.com/trials/study-evaluating-desvenlafaxine-succinate-sustained-release-dvs-sr-versus-placebo-in-peri-and-postmenopausal-women-7628https://curecurrent.com/trials/diabetes-mellitus-community-based-screening-in-minority-populations-7629https://curecurrent.com/trials/inhaled-technosphere-insulin-in-subjects-with-diabetes-mellitus-and-asthma-7630https://curecurrent.com/trials/effect-of-tegaserod-on-gastric-emptying-in-patients-with-diabetic-gastroparesis-7631https://curecurrent.com/trials/a-clinical-study-to-assess-the-efficacy-and-safety-of-three-doses-of-vildagliptin-in-patients-with-type-2-diabetes-7632https://curecurrent.com/trials/automated-diabetes-registry-tools-to-enhance-patient-self-management-and-provider-performance-feedback-7633https://curecurrent.com/trials/mitochondrial-function-in-pediatric-obesity-7634https://curecurrent.com/trials/go-fish-omega-3-fatty-acid-supplementation-in-diabetes-related-kidney-disease-7635https://curecurrent.com/trials/translating-the-diabetes-prevention-program-into-a-virtual-lifestyle-management-program-7636https://curecurrent.com/trials/ppar-combination-with-metformin-7637https://curecurrent.com/trials/intensive-exercise-to-improve-mitochondrial-dysfunction-in-pediatric-obesity-7638https://curecurrent.com/trials/a-trial-to-evaluate-bms-298585-as-monotherapy-in-subjects-with-type-2-diabetes-who-have-inadequate-glycemic-control-7639https://curecurrent.com/trials/study-of-int-747-in-patients-with-diabetes-and-presumed-nafld-7640https://curecurrent.com/trials/pneumatic-medicine-a-transformative-treatment-for-diabetic-peripheral-neuropathy-7641https://curecurrent.com/trials/reducing-distress-and-improving-self-care-in-diabetes-7642https://curecurrent.com/trials/a-study-to-test-the-combination-of-two-different-kinds-of-medications-for-the-treatment-of-diabetes-7643https://curecurrent.com/trials/periodontal-and-periapical-inflammation-and-pregnancy-7644https://curecurrent.com/trials/effect-of-rosiglitazone-versus-placebo-on-cardiovascular-performance-and-myocardial-triglyceride-7645https://curecurrent.com/trials/low-dose-versus-aggressive-inhibition-of-the-renin-angiotensin-aldosterone-ras-to-treat-microalbuminuria-7646https://curecurrent.com/trials/multiple-ascending-dose-study-of-bms-820132-in-patients-with-type-2-diabetes-7647https://curecurrent.com/trials/prevention-of-infection-using-a-topical-gentamicin-collagen-sponge-in-diabetic-patients-with-an-uninfected-foot-ulcer-7648https://curecurrent.com/trials/reducing-obesity-and-type-2-diabetes-in-high-risk-youth-7649https://curecurrent.com/trials/safety-study-of-ico-007-intravitreal-injection-to-treat-diabetic-macular-edema-7650https://curecurrent.com/trials/effect-of-platelet-concentrate-in-treatment-of-diabetic-ulcers-7651https://curecurrent.com/trials/rate-of-change-of-hba1c-dx-dt-may-predict-progression-to-type-2-dm-7652https://curecurrent.com/trials/a-study-to-compare-effects-of-gsk189075-in-combination-with-either-furosemide-or-hydrochlorothiazide-7653https://curecurrent.com/trials/a-comparison-of-study-drug-blood-levels-after-one-dose-of-gsk189075-in-subjects-with-normal-and-reduced-kidney-function-7654https://curecurrent.com/trials/a-study-to-compare-the-effect-on-heart-rhythm-of-3-days-of-gsk189075-placebo-or-moxifloxacin-in-healthy-adults-7655https://curecurrent.com/trials/safety-study-of-bms-903452-in-healthy-subjects-panel-1-7-relative-bioavailability-of-the-crystalline-and-amorphous-forms-7656https://curecurrent.com/trials/spinal-cord-stimulation-for-painful-diabetic-neuropathy-7657https://curecurrent.com/trials/resolution-of-comorbidities-safety-and-efficacy-of-greater-curvature-plication-in-obese-patients-7658https://curecurrent.com/trials/safety-study-of-topical-human-fgf-1-for-wound-healing-7659https://curecurrent.com/trials/integrating-depression-services-into-dm-management-7660https://curecurrent.com/trials/pediatric-atorvastatin-in-diabetes-intervention-trial-padit-7661https://curecurrent.com/trials/efficacy-of-aliskiren-in-the-treatment-of-diabetic-macular-edema-7662https://curecurrent.com/trials/testing-the-developmental-origins-hypothesis-7663https://curecurrent.com/trials/aspirin-dosing-in-diabetic-patients-7664https://curecurrent.com/trials/atrial-and-brain-natriuretic-peptides-in-bronchiolitis-7665https://curecurrent.com/trials/evaluating-the-effects-of-foot-orthotics-on-plantar-pressures-in-the-diabetic-population-7666https://curecurrent.com/trials/clinical-decision-support-consortium-7667https://curecurrent.com/trials/efficacy-study-of-pioglitazone-compared-to-glimepiride-on-coronary-atherosclerotic-disease-progression-in-subjects-with-7668https://curecurrent.com/trials/diabetes-therapy-to-improve-bmi-and-lung-function-in-cf-7669https://curecurrent.com/trials/efficacy-study-of-pioglitazone-and-glimepiride-on-the-rate-of-progression-of-atherosclerotic-disease-7670https://curecurrent.com/trials/efficacy-and-safety-study-of-tak-128-in-treating-subjects-with-diabetic-peripheral-neuropathy-7671https://curecurrent.com/trials/efficacy-and-safety-of-pioglitazone-and-azilsartan-in-treating-subjects-with-type-2-diabetes-mellitus-7672https://curecurrent.com/trials/pioglitazone-study-of-triglyceride-changes-in-subjects-with-type-2-diabetes-after-conversion-from-rosiglitazone-7673https://curecurrent.com/trials/study-to-compare-pioglitazone-and-rosiglitazone-in-subjects-with-type-2-diabetes-mellitus-and-dyslipidemia-7674https://curecurrent.com/trials/carnitine-levels-and-carnitine-supplementation-in-type-i-diabetes-7675https://curecurrent.com/trials/comparison-of-noninvasive-blood-glucose-concentrations-relative-to-finger-capillary-blood-glucose-references-7676https://curecurrent.com/trials/a-clinical-outcomes-study-to-measure-reduction-in-pain-and-numbness-during-administration-of-an-amino-acid-formulation-i-7677https://curecurrent.com/trials/study-to-evaluate-the-effect-of-renal-impairment-on-the-pharmacokinetics-of-pf-04991532-7678https://curecurrent.com/trials/efficacy-study-of-a-bioelectric-dressing-used-with-negative-pressure-wound-therapy-to-treat-diabetic-and-pressure-ulcers-7679https://curecurrent.com/trials/coping-skills-training-cst-for-children-with-chronic-health-conditions-7680https://curecurrent.com/trials/the-impact-of-pharmacist-recommendations-on-quality-of-care-in-diabetic-patients-7681https://curecurrent.com/trials/dose-finding-safety-and-efficacy-of-monthly-subcutaneous-canakinumab-administration-in-metformin-monotherapy-treated-typ-7682https://curecurrent.com/trials/tak-329-glucose-clamp-study-7683https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-acz885-in-patients-with-type-2-diabetes-7684https://curecurrent.com/trials/cognitive-behavioral-therapy-cbt-for-adherence-and-depression-in-type-1-diabetes-7685https://curecurrent.com/trials/ketones-mitochondrial-heteroplasmy-7686https://curecurrent.com/trials/study-of-alogliptin-combined-with-sulfonylurea-in-subjects-with-type-2-diabetes-mellitus-7687https://curecurrent.com/trials/efficacy-of-pioglitazone-on-bone-metabolism-in-postmenopausal-women-with-impaired-fasting-glucose-7688https://curecurrent.com/trials/a-study-examining-torcetrapib-atorvastatin-and-atorvastatin-effects-on-clinical-cv-events-in-patients-with-heart-disease-7689https://curecurrent.com/trials/botulinum-toxin-effects-on-plantar-ulcer-recurrence-7690https://curecurrent.com/trials/efficacy-and-safety-of-alogliptin-in-subjects-with-type-2-diabetes-7691https://curecurrent.com/trials/study-of-alogliptin-combined-with-pioglitazone-in-subjects-with-type-2-diabetes-mellitus-7692https://curecurrent.com/trials/efficacy-and-safety-of-alogliptin-combined-with-metformin-in-participants-with-type-2-diabetes-mellitus-7693https://curecurrent.com/trials/efficacy-and-safety-study-of-alogliptin-and-insulin-in-the-treatment-of-type-2-diabetes-7694https://curecurrent.com/trials/to-assess-safety-tolerability-pharmacokinetics-pharmacodynamics-and-the-effect-of-fasting-after-single-oral-doses-of-azd-7695https://curecurrent.com/trials/comparative-effectiveness-of-vitamin-d-and-repletion-strategies-7696https://curecurrent.com/trials/exploratory-study-of-iocide-oral-rinse-in-a-diabetic-population-7697https://curecurrent.com/trials/glu-xx-formulations-in-individuals-with-impaired-glucose-tolerance-7698https://curecurrent.com/trials/single-dose-study-to-study-the-absorption-metabolism-and-excretion-of-pf-04991532-7699https://curecurrent.com/trials/a-study-to-evaluate-the-pharmacodynamic-effects-of-single-dose-co-administration-of-lx4211-with-januvia-in-type-2-diabet-7700https://curecurrent.com/trials/renal-safety-of-iopamidol-versus-iodixanol-during-coronary-angiography-in-diabetic-patients-7701https://curecurrent.com/trials/observational-study-to-evaluate-the-effectiveness-and-safety-study-of-the-dexcom-g4-continuous-glucose-monitoring-system-7702https://curecurrent.com/trials/a-study-of-the-effect-of-incb013739-on-cortisone-reducing-enzyme-activity-in-obese-people-predisposed-to-diabetes-7703https://curecurrent.com/trials/the-effect-of-paricalcitol-capsules-on-reducing-albuminuria-in-patients-with-type-2-diabetic-nephropathy-being-treated-w-7704https://curecurrent.com/trials/a-relative-bioavailability-study-measuring-the-extent-and-rate-of-absorption-of-different-tablet-formulations-of-azd1656-7705https://curecurrent.com/trials/welchol-with-metformin-in-treating-patients-with-type-2-diabetes-7706https://curecurrent.com/trials/welchol-and-insulin-in-treating-patients-with-type-2-diabetes-7707https://curecurrent.com/trials/welchol-and-sulfonylurea-in-treating-patients-with-type-2-diabetes-7708https://curecurrent.com/trials/metanx-p-l-u-s-program-progress-through-learning-understanding-support-7709https://curecurrent.com/trials/socioeconomic-status-psychosocial-factors-and-cvd-risk-in-mexican-american-women-7710https://curecurrent.com/trials/glp1r-polymorphisms-and-response-to-glp1-7711https://curecurrent.com/trials/trial-of-fk614-in-type-2-diabetics-inadequately-controlled-on-a-sulfonylurea-7712https://curecurrent.com/trials/incretins-in-impaired-fasting-glucose-7713https://curecurrent.com/trials/a-study-of-ly2599506-in-patients-with-type-2-diabetes-7714https://curecurrent.com/trials/match-the-mexican-american-trial-of-community-health-workers-7715https://curecurrent.com/trials/prognostic-indicators-as-provided-by-the-epic-clearview-7716https://curecurrent.com/trials/bariatric-outcomes-longitudinal-database-bold-7717https://curecurrent.com/trials/the-triglyceride-lowering-effect-of-an-omega-3-fat-dha-in-addition-to-statin-therapy-for-patients-with-cad-or-diabetes-7718https://curecurrent.com/trials/effect-of-sevelamer-carbonate-on-oxidative-stress-in-patients-with-diabetic-nephropathy-7719https://curecurrent.com/trials/octreotide-acetate-in-microspheres-in-patients-with-diabetic-retinopathy-7720https://curecurrent.com/trials/intervention-groups-for-adolescents-with-type-1-diabetes-mellitus-7721https://curecurrent.com/trials/octreotide-acetate-in-microspheres-in-patients-with-diabetic-retinopathy-7722https://curecurrent.com/trials/early-diabetes-intervention-program-7723https://curecurrent.com/trials/effect-of-pasta-on-blood-glucose-response-in-normal-subjects-7724https://curecurrent.com/trials/metabolic-response-to-3-day-fast-versus-carbohydrate-free-diet-in-type-2-diabetes-7725https://curecurrent.com/trials/imaging-inflammation-in-autoimmune-diabetes-7726https://curecurrent.com/trials/effects-of-amlodipine-benazepril-in-the-hypertensive-african-american-population-with-type-2-diabetes-mellitus-7727https://curecurrent.com/trials/evaluation-of-a-medical-food-for-chronic-wounds-7728https://curecurrent.com/trials/the-impact-of-pancreatic-islet-cell-allotransplantation-on-cognitive-function-in-type-1-diabetes-mellitus-7729https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-pk-of-ctp-499-7730https://curecurrent.com/trials/lifestyle-modification-program-to-reduce-risk-of-coronary-heart-disease-in-latina-women-with-diabetes-7731https://curecurrent.com/trials/study-evaluating-desvenlafaxine-succinate-sustained-release-dvs-sr-in-adult-outpatients-with-pain-associated-with-diabet-7732https://curecurrent.com/trials/efficacy-study-of-high-dose-symlin-to-treat-type-2-diabetes-mellitus-7733https://curecurrent.com/trials/enhancing-support-for-women-with-type-2-diabetes-follow-up-7734https://curecurrent.com/trials/the-metabolic-effects-of-different-weight-loss-diets-7735https://curecurrent.com/trials/a-study-of-pf-05175157-in-healthy-volunteers-7736https://curecurrent.com/trials/a-study-comparing-skin-fluorescence-to-coronary-artery-calcification-7737https://curecurrent.com/trials/sensor-augmented-insulin-delivery-insulin-plus-glucagon-versus-insulin-alone-7738https://curecurrent.com/trials/safety-and-efficacy-of-xoma-052-in-subjects-with-type-2-diabetes-mellitus-on-stable-metformin-monotherapy-7739https://curecurrent.com/trials/safety-and-pharmacokinetics-study-of-xoma-052-in-subjects-with-type-2-diabetes-mellitus-7740https://curecurrent.com/trials/transitioning-open-heart-surgery-patients-from-insulin-infusions-to-detemir-7741https://curecurrent.com/trials/safety-tolerability-and-efficacy-study-of-mb07803-administered-to-patients-with-type-2-diabetes-mellitus-7742https://curecurrent.com/trials/seacare-s-care-coordination-for-diabetes-management-in-a-primary-care-office-7743https://curecurrent.com/trials/blood-glucose-stability-and-variability-on-two-diets-7744https://curecurrent.com/trials/an-18-week-efficacy-and-safety-study-of-saxagliptin-and-metformin-xr-combination-in-subjects-with-type-2-diabetes-7745https://curecurrent.com/trials/technology-intervention-for-diabetes-engagement-self-care-tides-7746https://curecurrent.com/trials/a-single-dose-study-in-japanese-and-western-healthy-subjects-to-investigate-the-safety-tolerability-and-pharmacokinetics-7747https://curecurrent.com/trials/safety-and-efficacy-of-dutogliptin-in-patients-with-type-2-diabetes-mellitus-t2dm-on-background-therapy-with-glimepiride-7748https://curecurrent.com/trials/study-comparing-effectiveness-of-intraperitoneal-insulin-administration-to-subcutaneous-insulin-administration-7749https://curecurrent.com/trials/safety-and-efficacy-of-dutogliptin-in-patients-with-type-2-diabetes-mellitus-t2dm-on-background-therapy-with-pioglitazon-7750https://curecurrent.com/trials/safety-and-efficacy-of-dutogliptin-in-patients-with-type-2-diabetes-mellitus-receiving-background-treatment-with-glimepi-7751https://curecurrent.com/trials/atenolol-exposure-as-risk-for-adverse-metabolic-responses-to-beta-blockers-7752https://curecurrent.com/trials/invest-international-verapamil-sr-trandolapril-study-7753https://curecurrent.com/trials/effect-of-case-management-using-home-monitoring-on-diabetes-and-blood-pressure-outcomes-7754https://curecurrent.com/trials/to-compare-the-effect-of-a-subcutaneous-canakinumab-administration-to-placebo-in-patients-with-impaired-glucose-toleranc-7755https://curecurrent.com/trials/effect-of-changing-diet-on-fasting-and-post-fat-load-lipoproteins-7756https://curecurrent.com/trials/prospective-evaluation-of-proteinuria-and-renal-function-in-diabetic-patients-with-progressive-renal-disease-7757https://curecurrent.com/trials/armor-analyzing-renal-mechanisms-of-creatinine-excretion-in-patients-on-tesaglitazar-7758https://curecurrent.com/trials/a-study-in-patients-with-type-2-diabetes-7759https://curecurrent.com/trials/a-study-comparing-the-safety-tolerance-and-efficacy-of-various-doses-of-sk-0403-versus-placebo-and-sitagliptin-100-mg-in-7760https://curecurrent.com/trials/using-scout-noninvasive-age-measurements-to-forecast-diabetes-complications-7761https://curecurrent.com/trials/insulin-glulisine-in-type-2-diabetic-patients-7762https://curecurrent.com/trials/the-effectiveness-of-continuous-glucose-monitoring-in-diabetes-treatment-for-infants-and-young-children-7763https://curecurrent.com/trials/efficacy-and-safety-of-pioglitazone-and-metformin-combination-therapy-in-treating-type-2-diabetes-mellitus-7764https://curecurrent.com/trials/study-of-the-glycemic-effects-of-nebivolol-compared-with-metoprolol-and-hctz-in-diabetic-hypertensive-patients-7765https://curecurrent.com/trials/effect-of-ziprasidone-on-glucose-plasma-lipids-in-diabetes-ii-and-schizophrenia-or-schizoaffective-disorder-7766https://curecurrent.com/trials/internet-diabetes-self-management-7767https://curecurrent.com/trials/the-potential-of-technology-to-improve-chronic-disease-management-and-quality-of-care-7768https://curecurrent.com/trials/an-open-label-comparison-of-duloxetine-to-other-alternatives-for-the-management-of-diabetic-peripheral-neuropathic-pain-7769https://curecurrent.com/trials/does-access-to-an-ehr-patient-portal-influence-chronic-disease-outcomes-7770https://curecurrent.com/trials/comparative-effects-of-chronic-treatment-with-olanzapine-and-risperidone-on-glucose-and-lipid-metabolism-7771https://curecurrent.com/trials/genetic-counseling-and-lifestyle-change-for-diabetes-prevention-7772https://curecurrent.com/trials/evaluate-the-side-effects-and-benefits-of-ras-130-with-or-without-diet-and-exercise-in-type-ii-diabetes-mellitus-7773https://curecurrent.com/trials/treating-nonalcoholic-steatohepatitis-nash-with-metformin-7774https://curecurrent.com/trials/a-study-for-patients-with-type-2-diabetes-mellitus-7775https://curecurrent.com/trials/real-world-aliskiren-use-in-diabetic-patients-7776https://curecurrent.com/trials/study-of-the-safety-and-efficacy-of-rgh-896-in-patients-with-diabetic-peripheral-neuropathic-pain-7777https://curecurrent.com/trials/a-single-research-site-bile-acid-sequestrant-acceptability-basa-scale-pilot-validation-study-7778https://curecurrent.com/trials/diabetes-prevention-in-women-with-a-recent-history-of-gestational-diabetes-focus-groups-7779https://curecurrent.com/trials/phase-1-study-of-bht-3021-in-subjects-with-type-1-diabetes-mellitus-7780https://curecurrent.com/trials/vascular-inflammation-in-adolescents-with-type-1-diabetes-7781https://curecurrent.com/trials/effect-of-pf-00734200-in-subjects-with-type-2-diabetes-7782https://curecurrent.com/trials/remote-management-of-diabetic-patients-via-data-transmission-by-accu-chek-360-software-7783https://curecurrent.com/trials/efficacy-evaluation-of-different-medication-combination-in-type-2-diabetes-treatment-7784https://curecurrent.com/trials/use-of-a-computer-assisted-decision-support-cads-system-in-management-of-patients-with-type-2-diabetes-7785https://curecurrent.com/trials/impact-of-accu-chek-360-in-veterans-with-type-2-diabetes-7786https://curecurrent.com/trials/effects-of-intensive-bolus-intravenous-insulin-delivery-on-metabolic-integrity-in-type-1-and-type-2-diabetes-7787https://curecurrent.com/trials/glucose-metabolism-in-the-immediate-and-short-term-follow-up-after-bariatric-surgery-7788https://curecurrent.com/trials/pk-pd-study-of-intranasal-insulin-in-type-i-diabetes-7789https://curecurrent.com/trials/effects-of-novel-fiber-on-glucose-metabolism-and-insulin-sensitivity-7790https://curecurrent.com/trials/effects-of-novel-fiber-on-glucose-homeostasis-in-individuals-at-risk-for-diabetes-7791https://curecurrent.com/trials/dpbrn-blood-sugar-testing-in-dental-patients-7792https://curecurrent.com/trials/prospective-evaluation-of-proteinuria-and-renal-function-in-non-diabetic-patients-with-progressive-renal-disease-7793https://curecurrent.com/trials/safety-tolerance-and-activity-of-he3286-in-patients-with-type-2-diabetes-mellitus-7794https://curecurrent.com/trials/effectiveness-and-safety-study-of-the-dexcom-g4-continuous-glucose-monitoring-system-in-children-and-adolescents-with-ty-7795https://curecurrent.com/trials/feasibility-study-for-training-pump-na-ve-subjects-to-use-the-paradigm-system-and-evaluate-effectiveness-7796https://curecurrent.com/trials/oasis-wound-matrix-oasis-mechanism-of-action-7797https://curecurrent.com/trials/blood-glucose-monitoring-system-clinical-study-7798https://curecurrent.com/trials/improving-metabolic-control-in-diabetic-young-children-7799https://curecurrent.com/trials/clinical-trial-of-sb-509-0401-in-subjects-with-diabetic-neuropathy-7800https://curecurrent.com/trials/does-bone-structure-explain-the-increased-fracture-risk-in-type-ii-diabetes-patients-a-pilot-study-7801https://curecurrent.com/trials/active-comparator-study-of-generex-oral-lyn-spray-and-injected-human-insulin-7802https://curecurrent.com/trials/a-multiple-dose-study-to-determine-safety-tolerability-and-pharmacokinetics-of-pf-04634817-in-healthy-adult-subjects-7803https://curecurrent.com/trials/improving-health-habits-in-impoverished-populations-7804https://curecurrent.com/trials/less-invasive-detection-and-treatment-of-very-early-coronary-artery-disease-in-patients-with-diabetes-mellitus-7805https://curecurrent.com/trials/research-study-in-patients-with-persistent-macular-edema-7806https://curecurrent.com/trials/patient-understanding-cognitive-debriefing-of-a-daily-diary-of-gastroparesis-symptoms-7807https://curecurrent.com/trials/using-networks-informatics-technology-and-education-in-care-for-people-with-diabetes-7808https://curecurrent.com/trials/treatment-trial-evaluating-long-acting-insulin-in-type-1-diabetes-7809https://curecurrent.com/trials/effect-of-a-decision-aid-about-statin-use-in-patients-with-type-2-diabetes-mellitus-7810https://curecurrent.com/trials/treatment-effect-of-saxagliptin-compared-with-placebo-in-patients-with-type-2-diabetes-and-renal-impairment-7811https://curecurrent.com/trials/effects-of-a-dietary-supplement-containing-l-arabinose-and-trivalent-patented-food-source-of-chromium-on-blood-glucose-a-7812https://curecurrent.com/trials/family-management-of-type-1-diabetes-in-children-7813https://curecurrent.com/trials/insulin-glargine-all-to-target-trial-7814https://curecurrent.com/trials/effects-of-quinapril-40-mg-with-alpha-lipoic-acid-or-placebo-on-diabetes-and-hypertension-7815https://curecurrent.com/trials/the-application-of-extremely-low-level-magnetic-fields-as-adjunctive-treatment-for-type-ii-diabetes-7816https://curecurrent.com/trials/taking-action-together-a-diabetes-prevention-program-7817https://curecurrent.com/trials/predictive-genetic-risk-assessment-trial-7818https://curecurrent.com/trials/the-effects-of-orally-ingesting-branched-chained-amino-acids-on-delayed-onset-muscle-soreness-in-diabetic-patients-7819https://curecurrent.com/trials/virtual-lifestyle-management-prevention-through-the-upmc-patient-portal-7820https://curecurrent.com/trials/lantus-versus-humalog-mix-as-add-on-therapy-in-type-diabetes-patients-failing-sulfonylurea-and-metformin-combination-tre-7821https://curecurrent.com/trials/sleep-and-glucose-regulation-in-youth-with-type-1-diabetes-mellitus-7822https://curecurrent.com/trials/a-study-of-stress-heart-imaging-in-patients-with-diabetes-at-risk-for-coronary-disease-7823https://curecurrent.com/trials/a-research-study-to-assess-the-mechanism-by-which-glucovance-metformin-and-glyburide-work-to-control-glucose-levels-in-p-7824https://curecurrent.com/trials/post-pci-cardiac-imaging-in-patients-with-diabetes-to-detect-coronary-artery-blockages-previously-opened-by-angioplasty-7825https://curecurrent.com/trials/a-research-study-to-determine-the-safety-and-efficacy-of-glucovance-compared-to-metformin-and-glyburide-in-children-and-7826https://curecurrent.com/trials/low-dose-cyclosporin-and-methotrexate-therapy-in-diabetes-7827https://curecurrent.com/trials/the-surgical-treatment-of-type-2-diabetes-mellitus-in-non-morbidly-obese-patients-a-community-hospital-study-7828https://curecurrent.com/trials/improving-diabetes-care-with-patient-decision-aids-a-trial-in-community-based-primary-care-7829https://curecurrent.com/trials/effect-of-nutritional-products-on-metabolic-parameters-in-subjects-with-type-2-diabetics-7830https://curecurrent.com/trials/a-study-to-evaluate-the-interaction-of-lx4211-and-metformin-in-healthy-subjects-7831https://curecurrent.com/trials/post-prandial-glucose-control-proof-of-principle-7832https://curecurrent.com/trials/study-of-two-oral-formulations-of-lx4211-in-patients-with-type-2-diabetes-mellitus-7833https://curecurrent.com/trials/the-effects-of-laf237-on-gastric-function-in-type-2-diabetes-7834https://curecurrent.com/trials/exercise-training-for-patients-with-poor-leg-circulation-7835https://curecurrent.com/trials/admixture-mapping-of-ethnic-and-racial-insulin-complex-outcomes-7836https://curecurrent.com/trials/comparison-of-the-leuven-protocol-with-the-glucommander-for-postoperative-control-of-blood-glucose-with-iv-insulin-7837https://curecurrent.com/trials/a-multiple-dose-study-of-pf-05161704-in-healthy-volunteers-7838https://curecurrent.com/trials/multiple-dose-study-of-pf-04991532-in-patients-with-type-2-diabetes-7839https://curecurrent.com/trials/single-ascending-dose-study-of-bms-820132-in-patients-with-type-2-diabetes-7840https://curecurrent.com/trials/study-of-lx4211-in-subjects-with-type-2-diabetes-mellitus-7841https://curecurrent.com/trials/niacin-for-treatment-of-elevated-cholesterol-and-triglycerides-in-hiv-infected-patients-7842https://curecurrent.com/trials/peer-led-and-telehealth-comparative-effectiveness-research-cer-adoption-for-diabetes-prevention-and-management-7843https://curecurrent.com/trials/experimental-study-to-validate-the-modified-glucose-disposal-test-7844https://curecurrent.com/trials/the-durable-trial-evaluating-the-durability-of-starter-insulin-regimens-in-patients-with-type-2-diabetes-ioov-7845https://curecurrent.com/trials/impact-of-type-2-diabetes-peer-counseling-on-behavioral-metabolic-and-health-outcomes-among-latinos-7846https://curecurrent.com/trials/a-study-to-assess-the-safety-tolerability-pharmacokinetics-pharmacodynamics-after-high-single-ascending-oral-doses-of-az-7847https://curecurrent.com/trials/coreg-cr-blood-vessel-stiffness-and-blood-vessel-function-7848https://curecurrent.com/trials/a-multicenter-open-label-single-dose-study-to-evaluate-the-effect-of-renal-insufficiency-on-the-pharmacokinetics-of-sk-0-7849https://curecurrent.com/trials/quitting-caffeine-for-better-glucose-metabolism-7850https://curecurrent.com/trials/finding-diabetes-mellitus-among-veterans-7851https://curecurrent.com/trials/pioglitazone-incretin-study-7852https://curecurrent.com/trials/adolescent-self-management-of-type-1-diabetes-an-intervention-completed-7853https://curecurrent.com/trials/vermont-diabetes-information-system-7854https://curecurrent.com/trials/a-trial-of-two-diets-for-weight-and-diabetes-management-7855https://curecurrent.com/trials/use-of-mct-oil-for-enhancement-of-weight-loss-and-glycemic-control-in-obese-diabetic-patients-7856https://curecurrent.com/trials/comparison-of-two-basal-insulins-for-patients-with-type-2-diabetes-taking-oral-diabetes-medicines-and-exenatide-7857https://curecurrent.com/trials/insulin-glargine-injection-treatment-in-place-of-thiazolidinedione-tzd-sulfonylurea-or-metformin-in-triple-agent-therapy-7858https://curecurrent.com/trials/a-study-to-evaluate-glucose-and-insulin-response-to-nutralin-7859https://curecurrent.com/trials/glimepiride-vs-metformin-as-monotherapy-in-pediatric-subjects-with-type-2-diabetes-mellitus-7860https://curecurrent.com/trials/insulin-glargine-v-rosiglitazone-as-add-on-therapy-in-patients-failing-sulfonylurea-and-metformin-combination-therapy-7861https://curecurrent.com/trials/compare-blood-sugar-level-between-lantus-in-the-morning-and-other-insulins-in-type-1-diabetes-adolescents-7862https://curecurrent.com/trials/insulin-glargine-rdna-origin-injection-vs-pioglitazone-as-add-on-therapy-in-patients-failing-monotherapy-with-sulfonylur-7863https://curecurrent.com/trials/insulin-glulisine-administered-pre-meal-versus-post-meal-in-adult-subjects-with-type-2-diabetes-mellitus-receiving-insul-7864https://curecurrent.com/trials/determine-whether-glycemic-control-is-different-between-lantus-a-3rd-oral-agent-when-failure-with-other-treatment-7865https://curecurrent.com/trials/insulin-glulisine-in-adult-subjects-with-type-2-diabetes-receiving-insulin-glargine-as-basal-insulin-7866https://curecurrent.com/trials/investigate-the-effect-of-azd1656-on-the-pharmacokinetics-of-digoxin-in-type-2-diabetes-mellitus-patients-7867https://curecurrent.com/trials/laparoscopic-gastric-bypass-for-type-2-diabetes-mellitus-with-body-mass-index-bmi-35-7868https://curecurrent.com/trials/transdermal-basal-insulin-patch-study-in-type-1-diabetes-7869https://curecurrent.com/trials/culturally-tailored-behavioral-diabetes-care-intervention-for-korean-americans-7870https://curecurrent.com/trials/pilot-study-of-the-effects-of-resveratrol-on-endothelial-function-in-subjects-with-type-2-diabetes-mellitus-7871https://curecurrent.com/trials/the-tantalus-ii-system-for-the-treatment-of-type-2-diabetes-a-randomized-study-7872https://curecurrent.com/trials/application-of-magnetic-fields-as-adjunctive-treatment-for-type-ii-diabetes-7873https://curecurrent.com/trials/to-assess-the-pharmacokinetics-of-azd1656-and-its-metabolite-in-type-2-diabetes-mellitus-patients-7874https://curecurrent.com/trials/a-study-to-evaluate-safety-tolerability-and-p-glucose-after-multiple-ascending-oral-doses-of-azd1656-in-type-2-diabetes-7875https://curecurrent.com/trials/to-evaluate-safety-and-tolerability-after-multiple-oral-doses-of-azd1656-in-type-2-diabetes-patients-on-top-of-insulin-7876https://curecurrent.com/trials/the-lancet-trial-a-trial-of-long-acting-insulin-injection-to-reduce-c-reactive-protein-in-patients-with-type-2-diabetes-7877https://curecurrent.com/trials/gallex-9-safety-and-tolerability-of-oral-tesaglitazar-when-added-to-insulin-therapy-in-patients-with-type-2-diabetes-7878https://curecurrent.com/trials/self-management-in-african-americans-with-diabetes-and-hypertension-7879https://curecurrent.com/trials/gallant-6-tesaglitazar-vs-pioglitazone-7880https://curecurrent.com/trials/gallex-6-study-to-evaluate-the-safety-and-tolerability-of-tesaglitazar-in-patients-with-type-2-diabetes-mellitus-7881https://curecurrent.com/trials/gallant-5-tesaglitazar-versus-metformin-7882https://curecurrent.com/trials/a-comparison-between-glargine-and-detemir-insulin-in-type-2-diabetes-7883https://curecurrent.com/trials/vascular-remodeling-and-the-effects-of-angiogenic-inhibition-in-diabetic-retinopathy-7884https://curecurrent.com/trials/vegf-gene-transfer-for-diabetic-neuropathy-7885https://curecurrent.com/trials/study-to-assess-the-pharmacokinetics-of-azd1656-during-coadministration-with-simvastatin-7886https://curecurrent.com/trials/comparison-of-two-basal-insulin-therapies-for-patients-with-type-1-diabetes-7887https://curecurrent.com/trials/comparison-of-two-basal-insulins-for-patients-with-type-2-diabetes-on-anti-hyperglycemic-medications-iope-7888https://curecurrent.com/trials/comparison-of-glycemic-control-among-diabetics-using-three-different-pen-needles-7889https://curecurrent.com/trials/a-drug-interaction-study-between-simvastatin-and-gsk376501-7890https://curecurrent.com/trials/study-to-investigate-the-safety-and-metabolism-of-gsk376501-in-overweight-subjects-7891https://curecurrent.com/trials/chromium-effects-on-insulin-and-vascular-function-in-people-at-risk-for-diabetes-7892https://curecurrent.com/trials/long-term-effects-of-insulin-plus-metformin-regimens-on-the-overall-and-postprandial-glycemic-control-of-patients-with-t-7893https://curecurrent.com/trials/efficacy-and-safety-of-twice-daily-insulin-lispro-low-mixture-compared-to-a-once-daily-long-acting-insulin-comparator-in-7894https://curecurrent.com/trials/24-hour-plasma-glucose-profiles-comparing-lispro-mix-75-25-vs-glargine-7895https://curecurrent.com/trials/effects-of-insulin-in-perceived-mood-symptoms-in-patients-with-type-2-diabetes-7896https://curecurrent.com/trials/project-diabetes-weight-gain-prevention-in-hispanic-girls-gemas-study-7897https://curecurrent.com/trials/comparison-of-colesevelam-hydrogen-chloride-hcl-powder-for-oral-suspension-versus-generic-cholestyramine-through-use-of-7898https://curecurrent.com/trials/homing-in-on-health-study-of-a-home-delivered-chronic-disease-self-management-program-7899https://curecurrent.com/trials/the-effect-of-a-coordinated-inpatient-diabetes-education-program-in-the-outpatient-setting-7900https://curecurrent.com/trials/diabetic-retinopathy-and-sickle-trait-7901https://curecurrent.com/trials/study-of-muraglitazar-versus-pioglitazone-in-type-2-diabetes-7902https://curecurrent.com/trials/mechanism-of-action-and-efficacy-of-muraglitazar-in-type-2-diabetes-7903https://curecurrent.com/trials/ppar-combo-with-sulfonylurea-7904https://curecurrent.com/trials/dose-ranging-study-with-lt-monotherapy-ppar-7905https://curecurrent.com/trials/a-study-to-evaluate-combining-metformin-with-muraglitazar-or-pioglitazone-in-type-2-diabetics-7906https://curecurrent.com/trials/study-comparing-muraglitazar-with-glimepiride-in-type-2-diabetics-who-are-not-controlled-with-metformin-alone-7907https://curecurrent.com/trials/a-placebo-controlled-safety-and-efficacy-study-of-int131-besylate-in-type-2-diabetes-with-an-active-comparator-7908https://curecurrent.com/trials/effect-of-insulin-glulisine-compared-to-insulin-aspart-and-insulin-lispro-when-administered-by-continuous-subcutaneous-i-7909https://curecurrent.com/trials/glycemic-index-and-cvd-a-crossover-feeding-study-7910https://curecurrent.com/trials/cognitive-behavioral-intervention-in-diabetes-self-management-7911https://curecurrent.com/trials/long-term-extension-study-to-evaluate-the-safety-of-dutogliptin-phx1149t-in-subjects-with-type-2-diabetes-mellitus-7912https://curecurrent.com/trials/safety-and-efficacy-study-of-dutogliptin-in-subjects-with-type-2-diabetes-mellitus-on-a-background-medication-of-metform-7913https://curecurrent.com/trials/long-term-study-to-evaluate-the-safety-of-dutogliptin-phx1149t-in-subjects-with-type-2-diabetes-mellitus-7914https://curecurrent.com/trials/internet-intervention-to-improve-rural-diabetes-care-7915https://curecurrent.com/trials/safety-and-efficacy-study-of-dutogliptin-phx1149t-in-subjects-with-type-2-diabetes-mellitus-on-a-background-medication-o-7916https://curecurrent.com/trials/single-dose-study-of-pf-04991532-in-healthy-subjects-7917https://curecurrent.com/trials/expanding-coverage-of-continuous-subcutaneous-insulin-infusion-in-pediatric-patients-with-diabetes-7918https://curecurrent.com/trials/efficacy-study-testing-herbal-extract-on-metabolic-parameters-in-subjects-with-type-2-diabetes-7919https://curecurrent.com/trials/comparison-of-different-types-of-resistant-starch-7920https://curecurrent.com/trials/effects-of-metformin-hydrochloride-hcl-in-combination-with-colesevelam-hcl-compared-to-metformin-hcl-alone-in-patients-w-7921https://curecurrent.com/trials/safety-and-tolerability-of-ms-r001-in-patients-with-diabetic-macular-edema-secondary-to-diabetic-retinopathy-7922https://curecurrent.com/trials/yoga-for-the-management-of-hiv-metabolic-syndromes-7923https://curecurrent.com/trials/noninvasive-skin-spectroscopy-for-diabetes-screening-7924https://curecurrent.com/trials/noninvasive-transcutaneous-glucometer-development-7925https://curecurrent.com/trials/improving-aspirin-use-in-diabetes-a-cluster-randomized-trial-7926https://curecurrent.com/trials/18-week-study-evaluating-safety-and-efficacy-of-olmesartan-amlodipine-and-hydrochlorothiazide-in-type-2-diabetics-7927https://curecurrent.com/trials/investigate-the-effect-of-azd1656-on-the-pharmacokinetics-of-pioglitazone-and-vice-versa-in-type-2-diabetes-mellitus-7928https://curecurrent.com/trials/islet-cell-transplantation-alone-in-patients-with-type-i-diabetes-mellitus-steroid-free-immunosuppression-7929https://curecurrent.com/trials/dallas-heart-study-2-return-clinic-visit-for-the-dallas-heart-study-cohort-7930https://curecurrent.com/trials/bone-turnover-in-type-2-diabetes-patients-7931https://curecurrent.com/trials/12-week-study-of-pf-00734200-for-the-treatment-of-type-2-diabetes-mellitus-in-subjects-treated-with-metformin-7932https://curecurrent.com/trials/rct-of-the-naturopathic-anti-inflammatory-diet-7933https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-pioglitazone-azilsartan-in-subjects-with-type-2-diabetes-mellitus-7934https://curecurrent.com/trials/nerve-function-in-older-diabetic-patients-who-are-undergoing-chemotherapy-for-metastatic-solid-tumors-7935https://curecurrent.com/trials/the-effect-of-vitamin-d-supplementation-on-glucose-metabolism-in-non-diabetic-african-american-adults-7936https://curecurrent.com/trials/effect-of-holofiber-socks-and-bedding-on-pain-and-quality-of-sleep-in-subjects-with-chronic-foot-pain-7937https://curecurrent.com/trials/evaluation-of-windowed-casts-with-and-without-regranex-gel-for-healing-diabetic-neuropathic-ulcers-7938https://curecurrent.com/trials/pancreas-allotransplantation-for-diabetic-nephropathy-and-mild-chronic-renal-failure-stage-study-7939https://curecurrent.com/trials/a-one-year-clinical-trial-assessing-the-usefulness-and-safety-of-inhaled-insulin-in-diabetics-with-asthma-7940https://curecurrent.com/trials/efficacy-of-structured-insulin-order-7941https://curecurrent.com/trials/enhancing-adherence-in-type-2-diabetes-the-enhance-study-7942https://curecurrent.com/trials/supplementation-with-conjugated-linoleic-acid-cla-as-complementary-therapy-in-the-management-of-type-2-diabetes-mellitus-7943https://curecurrent.com/trials/women-s-health-habits-study-7944https://curecurrent.com/trials/effect-of-vitamin-d-supplementation-on-hemoglobin-a1c-in-patients-with-uncontrolled-type-2-diabetes-mellitus-7945https://curecurrent.com/trials/improving-adherence-to-prescribing-guidelines-for-cholesterol-lowering-in-hospitalized-diabetic-patients-7946https://curecurrent.com/trials/study-evaluating-the-safety-and-efficacy-of-a-once-daily-dose-of-tigecycline-vs-ertapenem-in-diabetic-foot-infections-df-7947https://curecurrent.com/trials/improving-care-for-primary-care-patients-with-diabetes-and-poor-literacy-and-numeracy-skills-7948https://curecurrent.com/trials/efficacy-of-continuous-glucose-monitoring-in-subjects-with-type-1-diabetes-mellitus-on-multiple-daily-injections-mdi-or-7949https://curecurrent.com/trials/long-term-safety-study-of-inhaled-insulin-an-up-to-four-year-extension-of-therapy-in-subjects-with-type-1-or-type-2-diab-7950https://curecurrent.com/trials/effects-of-mycophenolate-mofetil-mmf-on-anti-hla-human-leukocyte-antigen-antibody-levels-in-patients-awaiting-cadaveric-7951https://curecurrent.com/trials/safety-and-efficacy-study-of-dutogliptin-phx1149t-to-treat-type-2-diabetes-mellitus-7952https://curecurrent.com/trials/effects-of-valsartan-and-aliskiren-on-hemostatic-indices-in-hypertensive-diabetics-7953https://curecurrent.com/trials/assessing-glucose-effects-of-sitagliptin-januvia-in-adult-patients-with-type-1-diabetes-7954https://curecurrent.com/trials/metabolic-analysis-in-human-sulfur-amino-acid-deficiency-7955https://curecurrent.com/trials/insulin-resistance-in-severely-obese-patients-7956https://curecurrent.com/trials/exubera-vs-lispro-in-a-lantus-based-regimen-for-improved-glycemic-control-in-type-2-diabetes-7957https://curecurrent.com/trials/evaluation-of-blood-volume-and-perceived-pain-during-fingerstick-monitoring-of-blood-glucose-7958https://curecurrent.com/trials/gene-expression-profiling-in-type-1-diabetes-7959https://curecurrent.com/trials/molecular-quantification-of-insulin-mrna-7960https://curecurrent.com/trials/computer-assisted-diabetes-self-management-interventions-7961https://curecurrent.com/trials/preventing-depression-recurrence-in-diabetes-7962https://curecurrent.com/trials/diabetes-control-and-complications-trial-dcct-7963https://curecurrent.com/trials/breaking-down-barriers-to-diabetes-self-care-7964https://curecurrent.com/trials/improving-outcomes-in-patients-with-kidney-disease-due-to-diabetes-7965https://curecurrent.com/trials/native-hawaiian-diabetes-intervention-program-7966https://curecurrent.com/trials/depression-in-juvenile-diabetics-7967https://curecurrent.com/trials/family-centered-diabetes-project-sharing-wisdom-7968https://curecurrent.com/trials/islet-cell-transplantation-alone-and-cd34-enriched-bone-marrow-cell-infusion-in-patients-with-diabetes-mellitus-steroid-7969https://curecurrent.com/trials/lifestyle-interventions-to-reduce-diabetes-risk-7970https://curecurrent.com/trials/improving-diabetes-in-primary-care-impact-7971https://curecurrent.com/trials/evaluation-of-vasopressin-in-the-vessels-of-ovarian-neoplasms-7972https://curecurrent.com/trials/safety-and-tolerability-of-azd1656-in-type-2-diabetes-mellitus-t2dm-patients-treated-with-metformin-and-sulfonylurea-7973https://curecurrent.com/trials/the-impact-of-a-video-cell-phone-reminder-system-on-glycemic-control-in-patients-with-diabetes-mellitus-7974https://curecurrent.com/trials/continuous-glucose-monitoring-in-patients-with-type-2-diabetes-7975https://curecurrent.com/trials/third-optimizing-anti-platelet-therapy-in-diabetes-mellitus-optimus-3-7976https://curecurrent.com/trials/study-of-xl784-in-patients-with-albuminuria-due-to-diabetic-nephropathy-7977https://curecurrent.com/trials/noninvasive-blood-glucose-monitoring-using-otoacoustic-emissions-7978https://curecurrent.com/trials/efficacy-and-safety-of-inhaled-insulin-compared-with-subcutaneous-human-insulin-therapy-in-adults-with-type-1-diabetes-7979https://curecurrent.com/trials/efficacy-and-safety-of-inhaled-insulin-compared-with-subcutaneous-human-insulin-therapy-in-adults-with-type-2-diabetes-7980https://curecurrent.com/trials/lidoderm-lidocaine-patch-5-in-diabetic-and-idiopathic-neuropathy-7981https://curecurrent.com/trials/family-centered-diabetes-project-7982https://curecurrent.com/trials/improving-medication-adherence-in-comorbid-conditions-7983https://curecurrent.com/trials/african-american-diabetes-intervention-project-7984https://curecurrent.com/trials/education-and-group-support-for-diabetic-hispanics-7985https://curecurrent.com/trials/insulin-resistance-and-central-nervous-system-cns-function-in-type-2-diabetes-7986https://curecurrent.com/trials/the-effect-of-a-probiotic-on-hepatic-steatosis-7987https://curecurrent.com/trials/phase-2b-study-of-gam501-in-the-treatment-of-diabetic-ulcers-of-the-lower-extremities-7988https://curecurrent.com/trials/lawrence-latino-diabetes-prevention-project-7989https://curecurrent.com/trials/study-to-evaluate-safety-and-efficacy-of-dutogliptin-in-type-2-diabetes-mellitus-subjects-with-moderate-and-severe-renal-7990https://curecurrent.com/trials/pivotal-study-of-the-intravenous-blood-glucose-ivbg-system-in-clinic-setting-7991https://curecurrent.com/trials/concurrent-use-of-two-continuous-glucose-monitoring-systems-in-adults-with-type-1-diabetes-mellitus-t1dm-7992https://curecurrent.com/trials/exercise-and-activity-guidance-in-older-adults-with-diabetes-7993https://curecurrent.com/trials/exubera-large-simple-trial-to-evaluate-long-term-pulmonary-and-cardiovascular-safety-7994https://curecurrent.com/trials/a-one-year-clinical-trial-assessing-the-usefulness-and-safety-of-inhaled-insulin-in-diabetics-with-copd-7995https://curecurrent.com/trials/effect-of-different-doses-of-salacinol-extract-on-glycemic-and-insulinemic-response-in-patients-with-type-2-diabetes-7996https://curecurrent.com/trials/coventry-outcomes-study-of-seniors-coss-a-comparative-effectiveness-study-to-evaluate-the-effect-of-a-multidisciplinary-7997https://curecurrent.com/trials/effects-of-fats-on-blood-glucose-in-people-with-and-without-type-2-diabetes-mellitus-7998https://curecurrent.com/trials/prevention-of-type-2-diabetes-mellitus-in-children-7999https://curecurrent.com/trials/randomized-trial-of-health-events-costs-in-diabetic-blacks-8000